ClickCease
+ 1-915-850-0900 spinedctors@gmail.com
Dooro Page

Niyad-jabku waa mid ka mid ah arrimaha caafimaadka dhimirka ee ugu badan gudaha Maraykanka. Cilmi-baadhisyada hadda jirta waxay soo jeedinaysaa in niyad-jabku ka yimaado isku-dhafka hidde-side, bayooloji, deegaan, iyo dhinacyo nafsi ah. Niyad-jabku waa xanuun maskaxeed oo weyn adduunka oo dhan oo culays dhaqaale iyo mid nafsi ah ku leh bulshada. Nasiib wanaag, niyad-jabka, xitaa xaaladaha ugu daran, waa la daweyn karaa. Marka hore ee ay daawadu bilaabmi karto, waa ka waxtar badan yahay.

 

Natiijo ahaan, si kastaba ha ahaatee, waxaa jirta baahi loo qabo biomarkers adag kuwaas oo gacan ka geysan doona hagaajinta ogaanshaha si loo dardargeliyo daawaynta iyo/ama habka daawaynta ee helitaanka bukaan kasta oo qaba xanuunka. Kuwani waa tilmaameyaal nafsiyeed oo ujeedo leh, oo joogitaanka loo isticmaali karo in lagu saadaaliyo ixtimaalka bilawga ama jiritaanka niyad-jabka, lagu hagaajiyo si waafaqsan darnaanta ama calaamadaha calaamadaha, waxay muujinayaan saadaalin iyo saadaalin ama la socdaan jawaabta waxqabadyada daweynta. Ujeedada maqaalkan soo socdaa waa in la muujiyo aragtiyaha dhow, caqabadaha hadda jira iyo rajada mustaqbalka ee ku saabsan helitaanka noocyo kala duwan oo biomarkers niyad-jabka iyo sida kuwani u caawin karaan hagaajinta ogaanshaha iyo daaweynta.

 

Biomarkers ee Niyad-jabka: Aragtidii dhawaa, Caqabadaha Hadda iyo Rajada Mustaqbalka

 

aan la taaban karin

 

Baadhitaanno badan oo cilmi-baaris ah ayaa ku lug yeeshay boqolaal biomarkers biomarkers oo loogu talagalay niyad-jabka, laakiin weli si buuxda uma ay qeexin doorkooda jirrada niyad-jabka ama waxay dejiyeen waxa aan caadiga ahayn ee bukaannada iyo sida macluumaadka bayoolojiga loo isticmaali karo si kor loogu qaado ogaanshaha, daaweynta iyo saadaalinta. Horumar la'aantani waxay qayb ahaan sabab u tahay dabeecadda iyo kala duwanaanshaha niyad-jabka, iyada oo lala kaashanayo heterogeneity habaysan oo ku dhex jira suugaanta cilmi-baarista iyo noocyo badan oo biomarkers ah oo leh karti, muujinta taas oo badanaa ku kala duwan tahay arrimo badan. Waxaan dib u eegis ku samaynaa suugaanta la heli karo, taas oo muujinaysa in calaamadaha ku lug leh bararka, neurotrophic iyo hababka dheef-shiid kiimikaadka, iyo sidoo kale qaybaha nidaamka neurotransmitter iyo neuroendocrine, waxay u taagan yihiin musharraxiin rajo leh. Kuwaas waxaa lagu cabbiri karaa hidde-side iyo epigenetic, transcriptomic iyo proteomic, metabolomic iyo qiimaynaha neuroimaging. Isticmaalka hababka cusub iyo barnaamijyada cilmi-baarista ee habaysan ayaa hadda loo baahan yahay si loo go'aamiyo haddii, iyo, kuwaas oo, biomarkers loo isticmaali karo in lagu saadaaliyo jawaabta daaweynta, loo habeeyo bukaanada daaweyno gaar ah iyo horumarinta bartilmaameedyada waxqabadyo cusub. Waxaan ku soo gabagabeyneynaa in uu jiro ballanqaad badan oo lagu dhimayo culeyska niyad-jabka iyada oo la sii horumarinayo lana ballaarinayo waddooyinkan cilmi-baarista.

 

Keywords: xanuunka niyadda, xanuunka weyn ee niyad-jabka, bararka, jawaab-celinta daawaynta, stratification, dawo gaar ah

 

Hordhac

 

Caqabadaha Caafimaadka Maskaxda iyo Xanuunada niyadda

 

In kasta oo cilmi-nafsiga uu leeyahay culays la xidhiidha cudurrada oo ka weyn nooc kasta oo kale oo lagu ogaanayo caafimaadka, 1 kala duwanaanshaha qaddarinta ayaa weli ka muuqda inta u dhaxaysa caafimaadka jidhka iyo maskaxda ee qaybo badan oo ay ka mid yihiin maalgelinta cilmi-baarista2 iyo daabacaadda.3 Dhibaatooyinka caafimaadka dhimirka soo wajaho waa la'aanta is-afgaradka ku xeeran kala-soocidda, ogaanshaha iyo daawaynta ka soo jeedda fahamka aan dhammaystirnayn ee geeddi-socodka asaasiga ah ee cilladahan. Tani aad ayay uga muuqataa xanuunka niyadda, qaybta ka kooban culayska keliya ee caafimaadka dhimirka.3 The most prevalent mode disorder, major depressive disorder (MDD), waa cudur kakan, kala duwanaansho ah kaas oo ilaa 60% bukaanada ay la kulmi karaan. qaar ka mid ah caabbinta daawaynta oo sii dheeraysa kana sii daraysa qaybaha waa la habayn karaa. Iyadoo la aqoonsanayo tan, hindisayaasha caalamiga ah ee lagu qeexayo noocyada-hoosaadka shaqada ayaa hadda socda, sida shuruudaha cilmi-baarista.4 Waxa la dhigay in calaamadaha bayoolojiga ay yihiin musharraxiinta mudnaanta u leh cillad-hoosaadka maskaxda.5

 

Hagaajinta Jawaabta Daaweynta Niyad-jabka

 

In kasta oo ay jiraan xulashooyin badan oo daaweyn ah oo loogu talagalay niyad-jabka weyn, kaliya ku dhawaad ​​​​saddex meelood meel bukaannada qaba MDD waxay gaaraan cafis xitaa marka la helo daawaynta lidka diiqadda ee ugu wanaagsan iyadoo la raacayo tilmaamaha la isku raacsan yahay iyo isticmaalka daryeelka ku saleysan cabbirka, iyo heerka jawaabta daawaynta waxay u muuqataa inay hoos u dhacdo daaweyn kasta oo cusub. .7 Intaa waxaa dheer, niyad-jabka u adkaysta daawaynta (TRD) waxay la xiriirtaa kororka daciifnimada shaqada, dhimashada, jirrooyinka iyo soo noqnoqda ama xaaladaha daba-dheeraada ee muddada dheer. natiijooyinka guud ee niyad-jabka. In kasta oo culeyska la taaban karo uu leeyahay TRD, cilmi-baarista aaggan ayaa ahayd mid aad u yar. Qeexitaannada TRD ma aha kuwo heersare ah, inkastoo isku dayadii hore: 8,9 shuruudaha qaarkood waxay u baahan yihiin hal tijaabo oo daaweyn ah oo ku guuldareysta in la gaaro 4% hoos u dhigista calaamadaha (laga bilaabo cabbir la ansixiyay ee darnaanta niyad-jabka), halka kuwa kalena ay u baahan yihiin guul-darrooyin buuxda ama aan ka jawaabin ugu yaraan laba antidepressants oo ku filan oo tijaabo ah oo fasalo kala duwan ah gudaha dhacdo si loo tixgeliyo TRD.50 Intaa waxaa dheer, diyaarinta iyo saadaasha caabbinta daaweynta ayaa la wanaajiyaa iyada oo lagu darayo sifooyinka muhiimka ah ee kiliinikada ee darnaanta iyo daba-dheeraada ee tirada daawaynta guuldareystay. .4,10 Si kastaba ha ahaatee, iswaafaq la'aantan qeexidda ayaa ka dhigaysa tarjumaada suugaanta cilmi-baarista ee TRD hawl aad u adag.

 

Si loo hagaajiyo ka jawaab celinta daawaynta, waxaa si cad waxtar u leh in la aqoonsado khatarta la saadaaliyay ee jawaab-la'aanta. Qaar ka mid ah saadaasha guud ee TRD ayaa lagu sifeeyay, oo ay ku jiraan la'aanta cafiska buuxda ka dib dhacdooyinkii hore, walaaca wadajirka ah, is-dilka iyo bilawga hore ee niyad-jabka, iyo sidoo kale shakhsiyadda (gaar ahaan hoos u dhigista, ku-tiirsanaanta abaal-marinta hooseeya iyo neuroticism sare) iyo arrimo hidde.12 Natiijooyinkan waxaa lagu xoojiyay dib u eegis lagu soo ururiyay caddaynta si gooni ah u daawaynta pharmacologic13 iyo cilmi-nafsiga14 ee niyad-jabka. Dawooyinka lidka diiqadda iyo daawaynta garashada-dabeecadu waxay muujinayaan ku dhawaad ​​waxtarka isbarbardhigga,15 laakiin sababo la xidhiidha hababka kala duwan ee ficilkooda ayaa laga yaabaa in la filayo inay yeeshaan saadaaliyayaal kala duwan oo jawaab celin ah. Iyadoo dhaawaca hore ee nolosha uu muddo dheer lala xiriiriyay natiijooyinka kiliinikada liidata iyo hoos u dhigista jawaabaha daaweynta, 16 calaamadihii hore waxay soo jeedinayaan in dadka leh taariikhda dhaawacyada carruurnimada laga yaabo inay si ka fiican uga jawaabaan maskaxiyan marka loo eego daaweynta farmashiyaha. shaandhaynta daawaynta ayaa gaadhay hawl-barashada.17

 

Dib-u-eeggani wuxuu diiradda saarayaa caddaynta taageeraya isticmaalka biomarkers sida qalab caafimaad oo faa'iido leh si kor loogu qaado jawaabta daaweynta niyad-jabka.

 

Biomarkers: Nidaamyada iyo Ilaha

 

Biomarkers waxay bixiyaan bartilmaameed suurtagal ah oo lagu ogaanayo saadaalinayaasha jawaab-celinta ee waxqabadyo kala duwan.19 Caddaynta ilaa taariikhda waxay soo jeedinaysaa in calaamadaha muujinaya dhaqdhaqaaqa bararka, neurotransmitter, neurotrophic, neuroendocrine iyo hababka dheef-shiid kiimikaadka ayaa laga yaabaa inay saadaaliyaan natiijooyinka caafimaadka maskaxda iyo jidhka ee shakhsiyaadka hadda niyad-jabsan. , laakiin waxaa jira wax badan oo is-khilaafsan oo u dhexeeya natiijooyinka.20 Dib-u-eegidan, waxaan diiradda saaraynaa shantan hababka noole.

 

Si loo helo faham buuxa oo ku saabsan dariiqyada molecular iyo ka qayb qaadashada xanuunka dhimirka, hadda waxaa loo arkaa inay muhiim tahay in la qiimeeyo heerar badan oo bayooloji ah, taas oo caan ku ah habka �omics. heerarka bayoolojiga oo mid kasta oo ka mid ah shanta nidaam lagu qiimayn karo, iyo ilaha suurtagalka ah ee calaamadaynta ee qiimayntan lagu samayn karo. Si kastaba ha ahaatee, ogow in iyada oo nidaam kasta lagu baari karo heer kasta oo omics ah, ilaha ugu wanaagsan ee cabbirku si cad ayay u kala duwan yihiin heer kasta. Tusaale ahaan, neuroimaging waxay bixisaa madal lagu qiimeeyo qaabdhismeedka maskaxda ama shaqada, halka baaritaannada borotiinka ee dhiigga ay si toos ah u qiimeeyaan calaamadaha. Transcriptomics21 iyo metabolomics1 ayaa si isa soo taraysa caan u ah, iyaga oo bixinaya qiimayn lagu samaynayo tirooyin aad u tiro badan oo calaamado ah, Mashruuca Human Microbiome Project waxa uu hadda isku dayayaa in uu aqoonsado dhammaan noolaha noolaha iyo halabuurka hidde-sidaha ee bani-aadmiga dhexdiisa. ; tusaale ahaan, hormoonnada sida cortisol hadda waxaa lagu tijaabin karaa timaha ama cidiyaha faraha (oo bixisa calaamad joogto ah) ama dhididka ( bixinta cabbir joogto ah), 22 iyo sidoo kale dhiigga, dareeraha cerebrospinal, kaadida iyo candhuufta.

 

Jaantuska 1 Calaamadaha noole ee suurtogalka ah ee niyad-jabka

 

Marka la eego tirada ilaha la geliyo, heerarka iyo nidaamyada ku lug leh niyad-jabka, maahan wax la yaab leh in miisaanka biomarkers ee leh awoodda tarjumaada uu yahay mid ballaaran. Gaar ahaan, marka isdhexgalka ka dhexeeya calaamadeeyayaasha la tixgeliyo, waxaa laga yaabaa inaysan u badneyn in baaritaanka hal biomarkers ee goonida ah ay dhalin doonto natiijooyin miro dhal ah oo lagu wanaajiyo dhaqanka caafimaad. Schmidt et al26 waxay soo jeedisay isticmaalka muraayadaha biomarker iyo, ka dib, Brand et al27 waxay qeexday guddi qabyo ah oo ku salaysan caddayn hore oo bukaan-socod iyo mid caafimaad oo loogu talagalay MDD, oo tilmaamaya 16 - xoog leh bartilmaameedyada biomarker, mid kasta oo ka mid ah dhif waa hal calaamad. Waxay ka kooban yihiin mugga walxaha cawlan ee hoos u dhaca (hippocampal, kiliyaha prefrontal iyo gobollada ganglia basal), isbeddelada wareegga wareegga, hypercortisolism iyo wakiillada kale ee hypothalamic-pituitary-adrenal (HPA) axis hyperactivation, cillad thyroid, dopamine oo yaraaday, noradrenaline ama 5-hydroxyindoleacetic acidic. , Kordhinta glutamate, korodhka superoxide dismutase iyo lipid peroxidation, adenosine cyclic 3?, 5?-monophosphate iyo dhaqdhaqaaqa borotiinka kinase ee mitogen-activated, korodhka cytokines proinflammatory, isbeddelka tryptophan, kynurenine, insulin iyo polymorphisms hidde gaar ah. Calaamadahaas laguma heshiin is-afgarad, waxaana loo cabbiri karaa siyaabo kala duwan; Way caddahay in shaqada xoogga leh iyo habaysan ay tahay inay wax ka qabato hawshan baaxadda leh si loo caddeeyo faa'iidooyinkooda caafimaad.

 

Ujeedooyinka dib u eegista

 

Dib-u-eegis si ula kac ah loo sameeyay, maqaalkani wuxuu raadinayaa inuu go'aamiyo baahiyaha guud ee cilmi-baarista biomarker ee niyad-jabka iyo ilaa xadka ay biomarkers-ku hayaan awoodda tarjumaada dhabta ah ee kor u qaadista jawaabta daaweynta. Waxaan ku bilaabaynaa inaan ka wada hadalno natiijooyinka ugu muhiimsan uguna xiisaha badan ee goobtan waxaanan ku hageynaa akhristaha dib u eegisyo gaar ah oo ku saabsan calaamadaha iyo isbarbardhigga. Waxaan soo bandhigeynaa caqabadaha hadda wajahaya iftiinka caddaynta, oo ay weheliso baahiyaha dhimista culeyska niyad-jabka. Ugu dambeyntii, waxaan horay u sii eegeynaa dariiqooyinka cilmi-baarista ee muhiimka ah si loola kulmo caqabadaha hadda jira iyo saameynta ay ku leeyihiin ku-dhaqanka bukaan-socodka.

 

Aragtidii dhawaa

 

Raadinta biomarkers-ka faa'iido leh kiliinikada ee loogu talagalay dadka qaba niyad-jabka ayaa soo saartay baaritaan ballaaran nus qarnigii la soo dhaafay. Daawaynta inta badan la isticmaalo waxaa laga soo qaatay aragtida monoamine ee niyad-jabka; ka dib, mala-awaalka neuroendocrine ayaa helay dareen badan. Sannadihii ugu dambeeyay, cilmi-baarista ugu waxtarka badan ayaa ku hareeraysan mala-awaalka bararka ee niyad-jabka. Si kastaba ha ahaatee, tiro badan oo maqaallo dib-u-eegis ah ayaa diiradda saaray dhammaan shanta nidaam; eeg Shaxda 1 iyo hoose si aad u hesho aragtiyo dhawaanahan oo dhan nidaamyada biomarker. Iyadoo lagu cabiray heerar badan, borotiinada dhiigga laga keenay ayaa si weyn loo baadhay waxayna bixiyaan ilo biomarker ah oo ku habboon, kharash-ool ah oo laga yaabo inay ku dhowdahay awoodda tarjumaada marka loo eego ilo kale; sidaas darteed, faahfaahin dheeraad ah ayaa la siiyaa biomarkers ku wareegaya dhiigga.

 

Shaxda 1 Dulmarka Biomarkers ee Niyad-jabka

 

Dib-u-eegis habaysan oo dhawaantan lagu sameeyay, Jani et al20 waxay baadhay biomarkers-ku-salaysan dhiiga ee niyad-jabka iyadoo lala kaashanayo natiijooyinka daawaynta. Kaliya 14 daraasadood ayaa lagu daray (la baaray ilaa horraantii 2013), 36 biomarkers ayaa la darsay kuwaas oo 12 ay ahaayeen saadaaliyayaal muhiim ah oo tilmaamayaasha jawaabta maskaxeed ama jireed ugu yaraan hal baaritaan. Kuwa loo aqoonsaday inay suurtogal tahay inay matalaan arrimaha khatarta ah ee jawaab-celinta la'aanta waxaa ka mid ah borotiinnada caabuqa: interleukin hooseeya (IL) -12p70, saamiga lymphocyte iyo tirada monocyte; calaamadaha neuroendocrine (dexamethasone aan la xakameynin cortisol, cortisol wareeg ah oo sarreeya, hormoonka tayroodh-kicinta oo yaraada); calaamadaha neurotransmitter (serotonin hoose iyo noradrenaline); dheef-shiid kiimikaad (kolestaroolka lipoprotein-cufnaanta-hooseeya) iyo arrimo neurotrophic (la dhimay S100 protein-binding protein B). Intaa waxaa dheer, dib u eegisyo kale ayaa ka warbixiyay ururada u dhexeeya biomarkers dheeraad ah iyo natiijooyinka daaweynta.

 

Shaxda 2 Biomarkers oo leh isticmaalka suurtogalka ah ee niyad-jabka

 

Natiijooyinka bararka ee niyad-jabka

 

Tan iyo markii Smith�s warqadda seminal ee qeexaysa mala-awaalka makrophage,31 suugaantan la aasaasay waxay heshay heerar kordhay oo ah calaamadaha proinflammatory ee bukaannada niyad-jabsan, kuwaas oo si ballaaran dib loogu eegay.32 dadka gacanta ku haya.37�38

 

IL-6 (P <0.001 ee dhammaan falanqaynta-meta; 31 cilmi-baaris ayaa lagu daray) iyo CRP (P<0.001; 20 daraasaadka) ayaa si joogto ah u muuqda oo si la isku halleyn karo kor loogu qaaday niyad-jabka.40 Kor u kaca tumor necrosis factor alpha (TNF?) ayaa lagu aqoonsaday daraasadihii hore (P <0.001),38 laakiin kala duwanaansho la taaban karo ayaa tan keentay mid aan la soo koobi karin marka la xisaabinayo baaritaanadii ugu dambeeyay (31 daraasaad) .40 IL-1? ayaa xitaa si aan macquul ahayn loola xiriiriyaa niyad-jabka, oo leh falanqayn-meta-analys oo soo jeedinaysa heerarka sare ee niyad-jabka (P=0.03),41 heerarka sare ee kaliya ee daraasadaha Yurub42 ama aan ka duwanayn kantaroolka. 40?,1 oo ay taageerto saameyn aad u weyn oo sare u kaca IL-44? ribonucleic acid oo saadaaliyay jawaab-celin liidata ee dawooyinka niyad-jabka;1 natiijooyinka kale ee kor ku xusan waxay khuseeyaan wareegga dhiigga ee cytokines. Chemokine monocyte chemoattractant protein-45 ayaa muujisay kor u kaca ka qaybgalayaasha niyad-jabsan ee hal falanqayn-meta-1 Interleukins IL-39, IL-2, IL-4, IL-8 iyo interferon gamma si weyn ugama duwana bukaanada niyad-jabsan iyo xakamaynta at a Heerka falanqaynta-meta-analytic, laakiin si kastaba ha ahaatee waxay muujiyeen karti marka la eego beddelka daaweynta: IL-10 ayaa lagu soo warramey inay sare u kacday kuwa qaba niyad-jabka ba'an mustaqbalka iyo qaybaha, 8 noocyo kala duwan oo isbeddel ah IL-46 iyo interferon gamma inta lagu jiro daaweynta Waxay ku dhaceen inta u dhaxaysa jawaab-bixiyeyaasha hore iyo kuwa aan jawaab-celinta ahayn,10 halka IL-47 iyo IL-4 ay hoos u dhaceen si waafaqsan calaamadaynta. 2 iyo CRP.48 Intaa waxaa dheer, TNF? waxa laga yaabaa inay yaraato oo kaliya daaweynta jawaabeyaasha, iyo tusmada calaamadaynta isku dhafan ayaa laga yaabaa inay muujiso bararka sii kordhaya ee bukaanka kuwaas oo aan ka jawaabin daaweynta. . Markaa, ugu yaraan qaar ka mid ah isbeddellada bararka inta lagu jiro daawaynta waxay u badan tahay inay sabab u yihiin dawooyinka niyad-jabka. Saamaynta bararka saxda ah ee dawooyinka lidka diiqadda ee kala duwan weli lama aasaasin, laakiin caddaynta iyadoo la adeegsanayo heerarka CRP waxay soo jeedinaysaa shakhsiyaadka inay si kala duwan uga jawaabaan daawaynta gaarka ah ee ku saleysan bararka aasaasiga ah: Harley et al6 ayaa sheegay in daweyn sare loo qaaday CRP oo saadaalisay jawaab-celin liidata ee daaweynta nafsaaniga ah ( garashada teraabiyada cilminafsiga), laakiin jawaabta wanaagsan ee nortriptyline ama fluoxetine; Uher et al1 waxay ku celiyeen natiijadan nortriptyline waxayna cadeeyeen saamaynta ka soo horjeeda ee escitalopram. Taas bedelkeeda, Chang et al10 waxay heleen CRP sare ee jawaabayaasha hore ee fluoxetine ama venlafaxine marka loo eego kuwa aan jawaabin. Intaa waxaa dheer, bukaanada qaba TRD iyo CRP sare waxay si fiican uga jawaabeen TNF? antagonist infliximab marka loo eego kuwa leh heerarka caadiga ah.43,49,50

 

Wadajir ahaan, caddayntu waxay soo jeedinaysaa in xitaa marka la xakameynayo arrimo ay ka mid yihiin index mass index (BMI) iyo da'da, jawaabaha caabuqa waxay u muuqdaan kuwo aan fiicneyn oo ku dhawaad ​​​​saddex meelood meel bukaanada qaba niyad-jabka.55,56 Nidaamka bararka, si kastaba ha ahaatee, waa mid aad u adag, iyo Waxaa jira biomarkers badan oo matalaya dhinacyo kala duwan oo nidaamkan ah. Dhawaan, cytokines cusub oo dheeraad ah iyo kiimiko ayaa keenay caddaynta cilladaha aan caadiga ahayn ee niyad-jabka. Kuwaas waxaa ka mid ah: borotiinka inhibitory macrophage 1a, IL-1a, IL-7, IL-12p70, IL-13, IL-15, eotaxin, granulocyte macrophage colony-stimulating factor,57 IL-5,58 IL-16,59 IL- 17,60 monocyte chemoattractant protein-4,61 thymus iyo chemokine activation-regulated,62 eotaxin-3, TNFb,63 interferon gamma-induced protein 10,64 serum amyloid A,65 soluble intracellular adhesion molecule66 iyo adhesion cell cell soluble.1.67

 

Natiijooyinka Qodobbada Kobaca ee Niyad-jabka

 

Marka la eego muhiimada suurtagalka ah ee arrimaha koritaanka aan neurotrophic ahayn (sida kuwa la xidhiidha angiogenesis), waxaanu tixraacaynaa biomarkers neurogenic iyada oo la raacayo qeexitaanka ballaaran ee qodobbada koritaanka.

 

Cunsurka neurotrophic ee maskaxda ka soo jeeda (BDNF) ayaa ah kuwa ugu badan ee kuwan la barto. Falanqaynta maadada-badan waxay muujinaysaa hoos u dhaca borotiinka BDNF ee serum, kaas oo u muuqda inuu kordho iyada oo la raacayo daaweynta antidepressant.68 kordhinta heerarka borotiinkan xitaa haddii aysan jirin cafis bukaan-socod.71 proBDNF ayaa si aad ah loo bartay marka loo eego qaabka qaan-gaarka ah ee BDNF, laakiin labaduba waxay u muuqdaan inay ku kala duwan yihiin shaqeyn (marka la eego saameynta ay ku leeyihiin tyrosine receptor kinase B) iyo dhawaanahan. caddayntu waxay soo jeedinaysaa in BDNF qaan-gaar ah laga yaabo inay hoos u dhigto niyad-jabka, proBDNF ayaa laga yaabaa in si xad dhaaf ah loo soo saaro.70 Korriinka neerfaha ee lagu qiimeeyay durugsan ayaa sidoo kale lagu soo warramey inay ka hooseyso niyad-jabka marka loo eego kontaroolada falanqaynta-meta-falanqeynta, laakiin waxaa laga yaabaa inaan lagu beddelin daaweynta antidepressant inkastoo ay jirto 72 Natiijooyin isku mid ah ayaa lagu soo warramey falanqaynta meta-analysis ee unugyada glialline-ka soo jeeda neurotrophic factor.73

 

Faa'iidada koritaanka xididdada xididada xididada (VEGF) waxay door ku leedahay kor u qaadista angiogenesis iyo neurogenesis oo ay weheliso xubnaha kale ee qoyska VEGF (tusaale, VEGF-C, VEGF-D) waxayna leedahay ballanqaad niyad-jab. dhawaan ayaa muujisay kor u kaca VEGF ee dhiiga bukaanada niyad jabsan marka loo eego kontaroolada (dhammaan daraasadaha 75; P<16) .0.001 Si kastaba ha ahaatee, VEGF hoose ayaa lagu aqoonsaday TRD76,77 iyo heerarka sare waxay saadaaliyeen jawaab-celin la'aan daaweynta antidepressant.78 Lama fahmin. sababta heerarka borotiinka VEGF loo sarreyn lahaa, laakiin waxaa laga yaabaa inay qayb ahaan loo aaneeyo dhaqdhaqaaqa proinflammatory iyo/ama korodhka xannibaadda xannibaadda maskaxda ee dawladaha niyad-jabka ah taas oo keenta hoos u dhigidda dareenka dareeraha maskaxda.79 Xiriirka ka dhexeeya VEGF iyo jawaabta daaweynta ma cadda. ; Daraasad dhowaan la sameeyay ma helin wax xiriir ah oo ka dhexeeya labada serum VEGF ama BDNF oo leh jawaab celin ama darnaanta niyad-jabka, inkastoo hoos u dhac ku yimid daaweynta antidepressant.80 Insulin-like koritaanka factor-81 waa arrin dheeraad ah oo leh hawlaha neurogenic oo laga yaabo in lagu kordhiyo niyad-jabka, taas oo muujinaysa isku dheelitir la'aanta hababka neurotrophic.1 Qodobka koritaanka aasaasiga ah ee fibroblast (ama FGF-82,83) waa xubin ka mid ah qoyska kobaca fibroblast waxayna u muuqataa mid ka sareysa niyad-jabka marka loo eego kooxaha kantaroolka.2 Si kastaba ha ahaatee, warbixinadu maaha kuwo joogto ah; mid ayaa la ogaaday in borotiinkani uu ka hooseeyay MDD marka loo eego kontaroolada caafimaadka leh, laakiin hoos u dhac dheeraad ah oo ay weheliso daaweynta niyad-jabka.84

 

Qodobbada koritaanka dheeraadka ah ee aan si ku filan loogu sahamin niyad-jabka waxaa ka mid ah tyrosine kinase 2 iyo fms-la mid ah tyrosine kinase-1 (sidoo kale loo yaqaan sVEGFR-1) kuwaas oo u dhaqma isdhexgalka VEGF, iyo tyrosine kinase reseptors (kaas oo isku xira BDNF) ayaa laga yaabaa in la yareeyo. in niyad-jabka.86 Qodobka koritaanka mandheerta sidoo kale waa qayb ka mid ah qoyska VEGF, laakiin laguma baran muunado si nidaamsan u niyad-jabsan ilaa aqoontayada.

 

Natiijooyinka Metabolic Biomarker ee Niyad-jabka

 

Biomarkers-ka ugu muhiimsan ee la xidhiidha jirrooyinka dheef-shiid kiimikaadka waxaa ka mid ah leptin, adiponectin, ghrelin, triglycerides, lipoprotein cufnaanta sare leh (HDL), glucose, insulin iyo albumin.87 Ururada u dhexeeya kuwan badan oo ka mid ah kuwan iyo niyad-jabka ayaa dib loo eegay: leptin88 iyo ghrelin89 waxay u muuqdaan kuwo ka hooseeya niyad-jabka. Marka loo eego kontaroolada ku yaal agagaarka waxaana laga yaabaa inay kordhiso daawaynta ka hortagga niyad-jabka ama cafiska. Iska caabbinta insulin waxaa laga yaabaa in lagu kordhiyo niyad-jabka, inkastoo qadar yar. hyperglycemia90 iyo hypoalbuminemia91 ee niyad-jabka ayaa lagu soo sheegay dib u eegista.

 

Baadhitaannada guud ahaan dawladaha dheef-shiid kiimikaadka ayaa noqda kuwo soo noqnoqda iyadoo la adeegsanayo muraayadaha metabolomics ee molecules yaryar iyadoo rajada laga qabo in la helo saxeex biochemical oo adag oo loogu talagalay cudurrada dhimirka. Daraasad dhowaan la sameeyay iyadoo la adeegsanayo qaabaynta sirdoonka macmalka ah, qayb ka mid ah dheef-shiid kiimikaad oo muujinaya kororka gulukooska.

 

Natiijooyinka Neurotransmitter ee niyad-jabka

 

Iyadoo fiiro gaar ah loo siiyay monoamines ee niyad-jabka ay keentay daaweyn guul leh, ma jiraan calaamado neurotransmitter ah oo adag oo la aqoonsaday si loo hagaajiyo daaweynta ku salaysan xulashada bartilmaameedyada monoamine ee antidepressants. Shaqadii dhowayd waxay tilmaamaysaa serotonin (5-hydroxytryptamine) 1A reseptor sida suurtogalka ah ee muhiimka u ah labadaba ogaanshaha iyo saadaasha niyad-jabka, iyadoo la sugayo farsamooyinka cusub ee hidda-socodka iyo sawirka.96 Waxaa jira daaweyn cusub oo suurtagal ah oo lagu beegsanayo 5-hydroxytryptamine; tusaale ahaan, iyadoo la adeegsanayo maamulka si tartiib tartiib ah u sii deynaya 5-hydroxytryptophan.97 Kordhinta gudbinta dopamine waxay la falgashaa neurotransmitters kale si loo hagaajiyo natiijooyinka garashada sida go'aan qaadashada iyo dhiirigelinta. iyada oo qayb ka ah jawaab-celinta walbahaarka ee niyad-jabka; Tani waxay hoos u dhigi kartaa wax soo saarka 98-hydroxytryptamine iyada oo loo marayo � fatahaad�. Dib-u-eegis dhawaan la sameeyay ayaa qeexaya aragtidan waxayna soo jeedinaysaa in TRD, tani ay dib u noqon karto (iyo 5-HT dib loo soo celiyay) iyada oo loo marayo daaweynta hababka kala duwan ee lagu beegsanayo neurotransmitters badan. , dheef-shiid kiimikaadka neurotransmitter sida 5-methoxy-99-hydroxyphenylglycol, ee noradrenaline, ama homovanillic acid, ee dopamine, ayaa inta badan la ogaaday inay kordhiso hoos u dhigista niyad-jabka ee daaweynta antidepressant100 ama in heerarka hoose ee dheef-shiid kiimikaadkan ay saadaaliyaan jawaab-celin wanaagsan Daaweynta SSRI.3

 

Natiijooyinka Neuroendocrine ee Niyad-jabka

 

Cortisol waa dhidibka ugu badan ee HPA biomarker ee lagu bartay niyad-jabka. Dib u eegisyo badan ayaa diirada saaray qiimaynta kala duwan ee waxqabadka HPA; guud ahaan, kuwani waxay soo jeedinayaan in niyad-jabka uu la xiriiro hypercortisolemia iyo in jawaabta baraarujinta cortisol inta badan la yareeyo.104,105 Tani waxaa taageeray dib-u-eegis dhowaan lagu sameeyay heerarka cortisol ee daba-dheeraaday ee lagu qiyaasay timaha, taageeraya fikradda cortisol hyperactivity ee niyad-jabka laakiin hypoactivity ee cudurrada kale sida sida xanuunka argagaxa.106 Intaa waxaa dheer, gaar ahaan, heerarka cortisol ee sarreeya ayaa laga yaabaa inay saadaaliyaan jawaabta liidata ee daaweynta nafsaaniga ah107 iyo antidepressant108. Taariikh ahaan, calaamada neuroendocrine ee ugu rajo-gelinta badan ee jawaabta daawaynta ee mustaqbalka ayaa ah tijaabada xakamaynta dexamethasone, halkaasoo cortisol-la'aanta ka dib maamulka dexamethasone ay la xiriirto suurtagalnimada hoose ee cafiska dambe. Si kastaba ha ahaatee, dhacdadan looma tixgalinay inay tahay mid ku filan oo adag codsiga kiliinikada. Calaamadaha la xidhiidha corticotrophin-hormoonka sii daaya hormoonka iyo hoormoonka adrenocorticotropin iyo sidoo kale vasopressin ayaa si aan kala sooc lahayn loo ogaaday in ay ku badan tahay niyad-jabka iyo dehydroepiandrosterone ayaa la ogaaday in la dhimay; saamiga cortisol iyo dehydroepiandrosterone ayaa laga yaabaa in kor loo qaado sida calaamad xasiloon oo ku jirta TRD, oo sii socota ka dib marka la cafiyo. caadi ka dhig daaweynta guuleysata ee niyad-jabka.109

 

Inta kor ku xusan, waxa kale oo muhiim ah in la tixgeliyo dariiqyada calaamadaha ee hababka, sida glycogen synthase kinase-3, protein kinase mitogen-activated iyo cyclic adenosine 3?,5?-monophosphate, oo ku lug leh caag synaptic112 oo wax laga beddelay antidepressants.113 Dheeraad ah Musharixiinta suurtagalka ah ee biomarker ee ku baahsan nidaamyada bayoolojiga gaar ahaan waxaa lagu cabbiraa iyadoo la adeegsanayo neuroimaging ama genetics. Iyada oo laga jawaabayo la'aanta kala duwanaanshaha genomic ee xooggan iyo macnaha leh ee u dhexeeya dadka niyad-jabsan iyo kuwa aan niyad-jabka ahayn, 114 habab hidde-socod oo cusub sida buundooyinka polygenic115 ama dhererka telomere116,117 ayaa caddayn kara faa'iido badan. Biomarkers dheeraad ah oo helaya caannimada ayaa baaraya wareegyada wareegyada ama kuwa biomarkers-ka taariikh nololeedka iyagoo isticmaalaya ilo kala duwan. Dhaqdhaqaaqa waxa uu bixin karaa qiimayn ujeedo leh oo ah hurdada iyo dhaqdhaqaaqa hurdada iyo nasashada iyada oo loo marayo xawaaraha mitirka, iyo aaladaha dhaqdhaqaaqa ayaa si sii kordheysa u cabbiri kara arrimo dheeraad ah sida soo-gaadhista iftiinka. Tani waxay noqon kartaa mid faa'iido badan u leh ogaanshaha marka loo eego warbixinnada bukaan-socodka ee sida caadiga ah loo isticmaalo waxayna bixin karaan saadaaliyayaal cusub oo ka jawaabaya daaweynta.118 Su'aasha ku saabsan biomarkers waa kuwa ugu ballanqaadka badan ee isticmaalka tarjumaadda waa mid adag, kaas oo lagu ballaariyay hoos.

 

Caqabadaha Hadda Jira

 

Mid kasta oo ka mid ah shanta hababka neurobiological ee dib loo eegay, caddayntu waxay raacdaa sheeko la mid ah: waxaa jira biomarkers badan oo jira kuwaas oo ku xiran xaaladaha qaarkood ee niyad-jabka. Calaamadahani waxay inta badan isku xidhan yihiin qaab kakan, oo ay adagtahay in la qaabeeyo. Caddeyntu waa mid aan iswaafaqayn, waxayna u badan tahay in qaar ka mid ah ay yihiin epiphenomena arrimo kale iyo qaar muhiim u ah kaliya qayb hoosaadyada bukaannada. Biomarkers waxay u badan tahay inay faa'iido u yeelan karaan iyada oo loo marayo waddooyin kala duwan (tusaale, kuwa saadaaliya jawaabta dambe ee daaweynta, kuwa tilmaamaya daawaynta gaarka ah sida ay u badan tahay inay waxtar u yeeshaan ama kuwa beddela waxqabadyada iyadoon loo eegin hagaajinta kiliinikada). Hababka cusub ayaa loo baahan yahay si loo kordhiyo joogtaynta iyo ku-dhaqanka kiliinikada ee qiimaynta bayoolojiga ee dadka dhimirka.

 

Kala duwanaanshaha biomarker

 

Kala duwanaanshaha biomarkers waqti ka dib iyo guud ahaan xaaladaha waxay ku xiran tahay noocyada qaarkood (tusaale, proteomics) marka loo eego kuwa kale (genomics). Xeerarka la jaanqaaday ee qaar badan ma jiraan ama lama aqbalin. Runtii, saamaynta arrimaha deegaanku ku leeyihiin calaamadeeyayaasha inta badan waxay ku xidhan tahay hal-abuurka hidde-sidaha iyo kala duwanaanshaha jidheed ee kale ee u dhexeeya dadka oo aan dhammaantood la xisaabin karin. Tani waxay ka dhigeysaa qiimeynta dhaqdhaqaaqa biomarker, iyo aqoonsashada cilladaha bayoolojiga, ay adagtahay in la tarjumo. Sababo la xiriira tirada biomarkers ee suurtagalka ah, qaar badan lama cabbirin si ballaaran ama guddi dhammaystiran oo ay la socdaan calaamado kale oo khuseeya.

 

Arrimo badan ayaa la soo sheegay si ay u beddelaan heerarka borotiinka guud ahaan nidaamyada bayoolojiga ee bukaannada qaba cilladaha saamaynta leh. Iyada oo ay weheliso arrimaha la xidhiidha cilmi-baarista sida muddada iyo xaaladaha kaydinta (taas oo keeni karta hoos u dhac ku yimaada xeryahooda qaarkood), kuwaas waxaa ka mid ah wakhtiga maalinta la cabbiray, qowmiyadda, jimicsiga, 119 cunto (tusaale, dhaqdhaqaaqa microbiome, gaar ahaan marka la eego in badi daraasadaha biomarker-ka dhiigga ay sameeyaan uma baahna muunad soonka), 120 sigaar cabbid iyo isticmaalka maandooriyaha,121 iyo sidoo kale arrimo caafimaad (sida caabuqa caabuqa, wadnaha iyo xididada ama jirrooyinka kale ee jirka). Tusaale ahaan, in kasta oo caabuqa bararka lagu arkay dadka niyad-jabsan laakiin haddii kale shakhsiyaad caafimaad qaba marka loo eego kooxaha aan niyad-jabka ahayn, shakhsiyaadka niyad-jabka ah ee sidoo kale leh xaalad la xidhiidha difaaca jirka waxay si joogto ah u leeyihiin xitaa heerar sare oo cytokines ah marka loo eego kuwa aan lahayn niyad-jab ama jirro. ku lug lahaanshaha suurtogalka ah ee xiriirka ka dhexeeya biomarkers, niyad-jabka iyo jawaabta daaweynta ayaa lagu qeexay hoos.

 

Cadaadiska. Jawaabaha endocrine iyo difaaca labadaba waxay leeyihiin door caan ah oo ka jawaabaya walaaca (fisiyooloji ama nafsi), iyo walbahaarka ku meel gaadhka ah ee wakhtiga ururinta muunada bayoolojiga ayaa dhif ah lagu qiyaasaa daraasadaha cilmi-baarista inkasta oo kala duwanaanshaha qodobkan u dhexeeya shakhsiyaadka laga yaabo in lagu xoojiyo hadda calaamadaha niyad-jabka. Cadaadiska nafsaaniga ah ee ba'an iyo kuwa daba-dheeraada labaduba waxay u dhaqmaan sidii caqabad difaac ah, oo xoojinaysa jawaabaha caabuqa ee muddada gaaban iyo muddada dheer. qof weyn.123,124 Inta lagu jiro khibrada caruurnimada ee naxdinta leh, bararka sii kordhaya ayaa sidoo kale lagu soo warramey kaliya carruurta hadda niyad-jabsan. ma jirto dhaawac hore oo nolosha ah hababka s, laakiin waxaa suurtogal ah in walbahaarka nolosha hore uu u horseedo shakhsiyaadka qaarkood inay u adkaystaan ​​dareen-celinta walaaca ee qaangaarnimada kuwaas oo la xoojiyay nafsi ahaan iyo/ama nafley ahaan.

 

shaqaynta garashada. Cilad-xumada neerfaha waxay si joogta ah ugu dhacdaa dadka qaba cillado saameyn leh, xitaa MDD.133 cilladaha garashada waxay u muuqdaan kuwo isku dhafan oo ay weheliyaan caabbinta daaweynta.134 Neurobiologically, HPA axis129 iyo neurotrophic Systems135 waxay u badan tahay inay door muhiim ah ka ciyaaraan xiriirkan. Neurotransmitters noradrenaline iyo dopamine waxay u badan tahay inay muhiim u yihiin hababka garashada sida barashada iyo xusuusta.136 Jawaabaha caabuqa ee sarreeya ayaa lala xiriiriyay hoos u dhaca garashada, waxayna u badan tahay inay saameeyaan shaqada garashada ee marxaladaha niyad-jabka,137 iyo cafiska, iyada oo loo marayo habab kala duwan.138 Runtii, Krogh et al139 ayaa soo jeediyay in CRP ay aad ugu dhowdahay waxqabadka garashada marka loo eego calaamadaha asaasiga ah ee niyad-jabka.

 

Da'da, jinsiga iyo BMI. Maqnaanshaha ama joogitaanka, iyo jihada kala duwanaanshaha bayooloji ee u dhexeeya ragga iyo dumarka ayaa si gaar ah u kala duwan caddaynta ilaa hadda. Kala duwanaanshaha hoormoonka Neuroendocrine ee ragga iyo dumarka waxay la falgalaan u nugulnaanta niyad-jabka.140 Dib-u-eegis lagu sameeyay daraasadaha caabuqa ayaa sheegay in xakamaynta da'da iyo jinsiga aysan saameyn ku yeelan kala duwanaanshaha xakameynta bukaan-socodka ee cytokines bararka (inkastoo xiriirka ka dhexeeya IL-6 iyo niyad-jabka uu hoos u dhacay marka da'du korodho, taas oo la socota aragtiyaha in caabuqa guud ahaan uu kordho da'da) .41,141 VEGF farqiga u dhexeeya bukaanada iyo kontaroolada ayaa ka weyn daraasadaha lagu qiimeynayo shaybaarka da'da yar, halka jinsiga, BMI iyo arrimaha bukaan-socodka aysan saameyn ku yeelan isbarbardhiggan heerka meta-analytic.77 Si kastaba ha ahaatee, La'aanta hagaajinta BMI ee baaritaanadii hore ee caabuqa iyo niyad-jabka ayaa u muuqda inay isku qasan yihiin kala duwanaansho aad u weyn oo laga soo sheegay kooxahan.41 Unugyada adipose-ka ee la ballaariyay ayaa si qeexan loo muujiyay si ay u kiciyaan wax soo saarka cytokine iyo sidoo kale inay si dhow ula xiriiraan calaamadaha dheef-shiid kiimikaadka.142 Sababtoo ah daawooyinka nafsaaniga ah waxaa laga yaabaa in lala xiriiriyo wei korodhka ght iyo BMI sare, kuwaasna waxa lala xidhiidhiyay caabbinta daawaynta ee niyad-jabka, tani waa aag muhiim ah in la baadho.

 

Daawada. Daraasado badan oo biomarker ah oo ku saabsan niyad-jabka (labadaba isdhaafsan iyo kuwa dheerba) ayaa soo ururiyay muunado salka u ah ka qaybgalayaasha aan la daweynin si loo yareeyo kala duwanaanshaha. Si kastaba ha ahaatee, qaar badan oo ka mid ah qiimaynahaas ayaa la qaataa ka dib marka la dhaqo muddada daawada, taas oo ka tagaysa arrin macquul ah oo la yaab leh oo ah isbeddelada haraaga ee physiology, oo ay uga sii dartay daawaynta ballaaran ee la heli karo kuwaas oo laga yaabo inay saameyn kala duwan ku yeeshaan caabuqa. Daraasadaha qaarkood ayaa ka saaray cilmi-nafsiga, laakiin maaha isticmaalka daawooyinka kale: gaar ahaan, kaniiniga ka hortagga uurka ayaa si joogta ah loo oggol yahay ka qaybgalayaasha cilmi-baarista oo aan la xakameynin falanqaynta, taas oo dhawaan la muujiyay in ay kordhiso hormoonnada iyo heerarka cytokine.143,144 Daraasado dhowr ah ayaa muujinaya in antidepressant. dawooyinku waxay saamayn ku leeyihiin jawaabta bararka, 34,43,49,145�147 HPA-axis,108 neurotransmitter,148 iyo neurotrophic149 dhaqdhaqaaqa. Si kastaba ha ahaatee, daawaynta badan ee suurtagalka ah ee niyad-jabku waxay leeyihiin sifooyin farmaajo oo kala duwan oo adag, iyagoo soo jeedinaya inay jiri karaan saameyno bayooloji oo kala duwan oo kala duwan oo daaweyn ah, oo ay taageerayaan xogta hadda jirta. Waxaa la aaminsan yahay in marka lagu daro saamaynta monoamine, daawooyinka serotonin-bartilmaameedka gaarka ah (ie, SSRIs) ay u badan tahay inay bartilmaameedsadaan Th2 isbeddelada caabuqa, iyo antidepressants noradrenergic (tusaale, SNRIs) waxay saameeyaan Th1 shift.150 Ilaa hadda suurtagal maaha in go'aamiso saamaynta daawooyinka shakhsi ahaaneed ama kuwa isku dhafan ee biomarkers. Kuwaas waxaa laga yaabaa inay dhexdhexaadiyaan arrimo kale oo ay ku jiraan dhererka daawaynta (tijaabooyin yar ayaa qiimeeya isticmaalka daawaynta muddada-dheer), muunadda kala duwanaanshaha iyo inaan la kala saarin ka qaybgalayaasha iyadoo laga jawaabayo daaweynta.

 

Heterogeneity

 

Habraaca. Sida kor ku xusan, kala duwanaanshaha (inta u dhaxaysa iyo daraasadaha) marka la eego daawaynta (iyo isku-dhafka) ka qaybgalayaashu waxay qaadanayaan oo ay hore u qaateen waxay ku xiran tahay inay soo bandhigaan kala duwanaansho cilmi-baariseed, gaar ahaan cilmi-baarista biomarker. Intaa waxa dheer, naqshado kale oo badan iyo sifooyin muunad ah ayaa ku kala duwan daraasadaha oo dhan, sidaas awgeed waxay sii kordhinaysaa dhibka xagga tarjumaada iyo u sababaynta natiijooyinka. Kuwaas waxaa ka mid ah cabbiraadaha cabbiraadda biomarker (tusaale, xirmooyinka baaritaanka) iyo hababka ururinta, kaydinta, habaynta iyo falanqaynta calaamadaha niyad-jabka. Hiles et al141 waxay baadhay qaar ka mid ah ilaha iswaafaqsanaanta ee suugaanta ku saabsan caabuqa waxayna ogaadeen in saxnaanta ogaanshaha niyad-jabka, BMI iyo cudurrada wadajirka ah ay ugu muhiimsan yihiin in lagu xisaabtamo qiimeynta bararka durugsan ee u dhexeeya kooxaha niyad-jabsan iyo kuwa aan niyad-jabka ahayn.

 

Clinical Kala duwanaanshaha ballaaran ee dadka niyad jabsan ayaa si wanaagsan loo diiwaangeliyay151 waana qayb muhiim ah oo ka mid ah natiijooyinka isbarbardhigga ah ee ku jira suugaanta cilmi-baarista. Waxay u badan tahay in xitaa marka la baarayo, astaamaha bayoolojiga aan caadiga ahayn ay ku xaddidan yihiin qaybo hoose oo shakhsiyaad ah oo laga yaabo inayna xasilloonayn muddo ka dib. Kooxo-hoosaadyo wada-jir ah oo dadka qaba niyad-jabka ayaa laga yaabaa in lagu aqoonsan karo arrimo nafsi ah iyo kuwo bayooloji isugu jira. Hoosta, waxaan ku qeexaynaa suurtagalnimada sahaminta kooxo-hoosaadyada si loo daboolo caqabadaha ay keenayaan kala duwanaanshaha biomarker iyo kala duwanaansho.

 

Noocyada hoose ee niyad-jabka

 

Ilaa hadda, ma jiraan koox-hoosaadyo isku mid ah oo ka tirsan xaaladaha niyad-jabka ama cilladaha oo si isku-hallayn ah u awooday inay kala soocaan bukaanka iyadoo lagu saleynayo bandhigyada calaamadaha ama ka jawaab celinta daaweynta. waxay kicin kartaa dariiqa loo maro daawaynta habaysan. Kunugi et al152 ayaa soo jeediyay afar nooc oo suurtagal ah oo ku saleysan doorka hababka neurobiological ee kala duwan oo muujinaya noocyada hoosaadyada kiliinikada ee niyad-jabka: kuwa qaba hypercortisolism oo soo bandhigaya niyad-jabka melancholic, ama hypocortisolism oo ka tarjumaysa nooc hoose oo aan caadi ahayn, qayb ka mid ah dopamine-la xidhiidha bukaannada kuwaas oo laga yaabo in si muuqata ula yimaad anhedonia (oo si fiican uga jawaabi kara, tusaale, aripiprazole) iyo nooc hoosaad barar ah oo lagu garto barar sare. Maqaallo badan oo diiradda saaraya bararka ayaa qeexay kiiska jiritaanka nooc hoosaad barar ah oo ku jira niyad-jabka.153 Xiriirinta bukaan-socodka ee caabuqa sarreeya ayaa weli aan la go'aamin oo isku dayo yar oo toos ah ayaa la sameeyay si loo ogaado ka qaybgalayaasha laga yaabo inay ka kooban yihiin kooxdan. Waxaa la soo jeediyay in dadka qaba niyad-jabka aan caadiga ahayn ay yeelan karaan heerar sare oo barar ah marka loo eego nooca melancholic, 55,56,154,155 taas oo laga yaabo in aan la socon natiijooyinka ku saabsan dhidibka HPA ee melancholic iyo noocyada hoose ee niyad-jabka. TRD156 ama niyad-jabka leh calaamadaha somatic ee caanka ah37 ayaa sidoo kale loo arkaa inay tahay nooc hoosaadyo barar ah, laakiin neurovegetative (hurdo, rabitaanka cuntada, luminta libido), niyadda (oo ay ku jiraan niyadda hoose, isdilka iyo xanaaqa) iyo calaamadaha garashada (oo ay ku jiraan eexda saameeya iyo dembiyada)157 dhammaan u muuqdaan kuwo la xidhiidha profiles bayooloji. Musharrixiinta kale ee suurtogalka ah ee nooca hoosaadka bararka ayaa ku lug leh waayo-aragnimada dabeecadda jirrada-sida calaamadaha158 ama cilladda dheef-shiid kiimikaadka.159,160

 

U janjeerta xagga (hypo) waali waxay kala saari kartaa bayoloji ahaan bukaanka qaba niyad-jabka. Caddaymaha hadda waxay soo jeedinayaan in cudurrada laba-cirifoodka ay yihiin kooxo badan oo maskaxeed, iyada oo xanuunka laba-cirifoodka subsyndromal la helay si ka badan sidii hore loo aqoonsaday. celceliska waqtiga si loo saxo cudurka in ka badan toban sano ka badan iyo dib u dhacu keenaya darnaanta weyn iyo kharashka guud ee jirada. Qodobbada laga yaabo in ay kala soocaan unipolar iyo niyad-jabka laba-cirifoodka ayaa leh saameyn la taaban karo.161 Xanuunnada laba-cirifoodka waxay u badan tahay in aan la ogaanin qaar ka mid ah baaritaannada biomarker hore ee MDD, iyo caddaynta caddaynta ayaa muujisay kala duwanaanshaha dhaqdhaqaaqa dhidibka HPA162 ama caabuq163 ee u dhexeeya laba-cirifoodka iyo unugyadu. nuxur Si kastaba ha ahaatee, isbarbardhiggani waa mid aad u yar, oo leh cabbiro muunad yar, oo la aqoonsaday saameyn aan muhiim ahayn ama dad la shaqaaleysiiyay oo aan si fiican loogu aqoonin cudurka. Baaritaanadani sidoo kale ma baarayaan doorka ka jawaab celinta daaweynta ee cilaaqaadkan.

 

Laba-cirifoodka167 iyo caabbinta daawaynta168 labaduba maaha dhismayaal kala-duwan oo been ku socda, taas oo kordhinaysa caqabada aqoonsiga nooca-hoosaadka. Marka laga reebo qoraal-hoosaadka, waxaa xusid mudan in cillado badan oo nafleyda ah oo aan caadi ahayn oo lagu arkay niyad-jabka ay si isku mid ah uga helaan bukaannada qaba cudurrada kale. Sidaa darteed, baaritaannada transdiagnostic sidoo kale waa muhiim.

 

Caqabadaha Qiyaasta Biomarker

 

Doorashada biomarker. Tirada badan ee biomarkers faa'iido u leh ayaa soo bandhigaysa caqabad xagga cilmi nafsiga ah si loo go'aamiyo calaamadaha lagu lug leeyahay habka iyo cidda. Si loo kordhiyo caqabada, in yar oo ka mid ah biomarkers-ka ayaa lagu sameeyay baaritaan ku filan oo ku saabsan niyad-jabka, iyo inta badan, doorkooda saxda ah ee dadka caafimaadka qaba iyo kuwa bukaan-socodka ah si fiican looma fahmin. Iyada oo ay taasi jirto, tiro isku dayo ah ayaa la sameeyay si loo soo jeediyo muraayadaha biomarker ee mustaqbalka. Marka lagu daro Brand et al 16 oo ah calaamado leh awood xoog leh, 27 Lopresti iyo al waxay qeexaysaa jaangooyo dheeraad ah oo dheeraad ah oo ah calaamadaha cadaadiska oksaydhka leh ee suurtogalka ah hagaajinta jawaabta daaweynta. nidaamyada bayoolojiga (BDNF, cortisol, TNF milmi? nooca receptor II, alpha28 antitrypsin, apolipoprotein CIII, factor koritaanka epidermal, myeloperoxidase, prolactin iyo iska caabin) in la ansaxiyo iyo shaybaarada la MDD. Marka la isku daro, qiyaasta isku dhafan ee heerarkan ayaa awood u leh inay kala soocaan MDD iyo kooxaha xakamaynta 1% ~ 80% saxsanaanta.90 Waxaan soo jeedineynaa in xitaa kuwani aysan daboolin dhammaan musharaxiinta suurtagalka ah ee goobtan; eeg Shaxda 169 si aad u qeexdo biomarkers ee leh niyad-jabka, oo ka kooban labadaba kuwa leh saldhigga caddaynta iyo calaamado cusub oo rajo leh.

 

Technology. Horumarka tignoolajiyada awgeed, hadda waa suurtogal (runtii, ku habboon) in la cabbiro tiro badan oo biomarkers isku mar ah oo qiimo jaban leh iyo dareen ka sarreeya kii hore. Waqtigan xaadirka ah, awooddan lagu cabbiro xeryahooda badan ayaa ka horreeya awooddayada si wax ku ool ah u falanqeeyo oo u tarjumo xogta, 170 wax sii wadi doona kor u kaca hababka biomarker iyo calaamado cusub sida metabolomics. Tani waxay inta badan sabab u tahay faham la'aanta ku saabsan doorarka saxda ah ee iyo xiriirka ka dhexeeya calaamadeeyayaasha, iyo faham la'aanta sida calaamadeeyayaasha la xidhiidha ay ula xiriiraan heerar kala duwan oo bayooloji ah (tusaale, hidde-side, qoraal, borotiin) gudaha iyo inta u dhaxaysa shakhsiyaadka. Xogta weyn ee la isticmaalayo habab cusub oo lafo-gur iyo heerar ayaa gacan ka geysan doona wax ka qabashada tan, iyo habab cusub ayaa la soo jeediyay; Hal tusaale ayaa ah horumarinta habka tirakoobka ee ku salaysan falanqaynta qulqulka ku salaysan si loo ogaado calaamadaha dheef-shiid kiimikaadka cusub ee ku salaysan falcelinta u dhexeeya shabakadaha iyo isku-dhafka hidda-wadaha xogta dheef-shiid kiimikaadka. xogta si loo saadaaliyo natiijada daawaynta ee daraasadaha xogta weyn.171

 

Isku-darka biomarkers. In la baaro array of biomarkers isla mar ahaantaana waa beddelka in la baaro calaamadaha go'doonsan oo bixin kara aragti sax ah oo ku saabsan shabakadaha adag ee nidaamyada bayoolojiga ama shabakadaha. iyo isdhexgalka si fiican ayaa loo fahmay), xogta biomarker ka dibna waa la isku dari karaa ama la tilmaami karaa. Hal caqabad ayaa ah aqoonsiga habka ugu wanaagsan ee tan loo sameeyo, waxaana laga yaabaa inay u baahato kobcinta tignoolajiyada iyo/ama farsamooyinka falanqaynta cusub (eeg qaybta Taariikh ahaan, saamiga u dhexeeya laba biomarkers oo kala duwan ayaa keenay natiijooyin xiiso leh.26 Tiro yar ayaa la sameeyay si loo isku daro xogta biomarker ee miisaan weyn, sida kuwa isticmaalaya falanqaynta qaybta asaasiga ah ee shabakadaha cytokine proinflammatory. loo beddelay dhibcaha cabbirka hal-saameynta ah ee daraasad kasta, iyo guud ahaan waxay muujisay barar aad u sarreeya ka hor inta aan la daaweyn antidepressant, saadaalinta jawaab-celinta soo socota ee daraasadaha bukaan-socodka. Qaybaha biomarker-ka isku dhafan labaduba waa caqabad iyo fursad cilmi-baaris mustaqbalka ah si loo ogaado natiijooyin macno leh oo la isku halleyn karo oo lagu dabaqi karo si loo hagaajiyo natiijooyinka daaweynta. dhidibka HPA iyo hababka dheef-shiid kiimikaadka) kuwaas oo lagu tilmaamay inay ku kala duwan yihiin shakhsiyaadka niyad-jabsan iyo kantaroolka daraasad hore oo ka kooban kuwan dhibcaha khatarta ah kuwaas oo ku kala duwan laba muunado oo madaxbannaan iyo koox xakameyn leh> 109,173% dareenka iyo gaar ahaaneed.174

 

Xog weyn. Isticmaalka xogta weyn waxay u badan tahay inay lagama maarmaan u tahay wax ka qabashada caqabadaha hadda jira ee ku xeeran kala duwanaanshaha, kala duwanaanshaha biomarker, aqoonsiga calaamadaha ugu wanaagsan iyo keenista goobta tarjumaad, cilmi-baaris lagu dabaqay niyad-jabka. Si kastaba ha ahaatee, sida kor ku xusan, tani waxay keenaysaa caqabadaha tignoolajiyada iyo sayniska.175 Cilmiga caafimaadka ayaa dhawaan bilaabay adeegsiga falanqaynta xogta weyn, toban sano ama wax ka badan marka loo eego qaybta ganacsiga. Si kastaba ha ahaatee, daraasadaha sida iSPOT-D152 iyo isbahaysiga sida Consortium psychiatric Genetics Consortium176 waxay ku horumarayaan fahamkayaga hababka bayoolojiga ee dhimirka. Algorithms-barashada mishiinku waxay leeyihiin, daraasado aad u yar, ayaa bilaabay in lagu dabaqo biomarkers ee niyad-jabka: baaritaan dhowaan la sameeyay ayaa xogta laga helay> 5,000 ka qaybgalayaasha 250 biomarkers; Xog-ururin badan ka dib, mashiin-barashada dib-u-celinta ayaa la sameeyay, taasoo muujinaysa 21 biomarkers oo suurtagal ah. Falanqaynta dib-u-noqoshada dheeraadka ah ka dib, saddex biomarkers ayaa loo doortay inay si xooggan ula xiriiraan calaamadaha niyad-jabka (cabbirka unugyada cas ee dhiigga oo aad u kala duwan, gulukoosta serum iyo heerarka bilirubin). Qorayaashu waxay soo gabagabeeyeen in xogta weyn loo isticmaali karo si wax ku ool ah si loo soo saaro mala-awaalka.177 Mashruucyada waaweyn ee biomarker phenotyping ayaa hadda socda waxayna gacan ka geysan doonaan horumarinta safarkayaga mustaqbalka neurobiology ee niyad-jabka.

 

Rajada mustaqbalka

 

Aqoonsiga Guddiga Biomarker

 

Natiijooyinka suugaanta ilaa maanta waxay u baahan yihiin ku-noqoshada daraasado waaweyn. Tani waxay si gaar ah run ugu tahay biomarkers-ka novel, sida chemokine thymus iyo chemokine-ka-habeeya firfircoonida iyo factor factor tyrosine kinase 2, taas oo, aqoontayada, aan lagu baarin bukaan-socodka niyad-jabka iyo caafimaadka caafimaadka qaba. Daraasaadka xogta waaweyn waa in ay qiimeeyaan baallaha biomarker oo dhammaystiran oo ay isticmaalaan farsamooyin falanqayn oo casri ah si ay si buuxda u hubiyaan xidhiidhada u dhexeeya calaamadeeyayaasha iyo arrimaha wax ka beddelaya kuwa bukaan-socodka iyo kuwa aan bukaan-socodka ahayn. Intaa waxaa dheer, ku-noqoshada baaxadda weyn ee falanqaynta qaybta asaasiga ahi waxay aasaasi kartaa kooxo aad isugu xidhan oo biomarkers ah waxayna sidoo kale ku wargelin kartaa isticmaalka isku-dhafan ee cilmi-nafsiga bayoolajiga, taas oo kor u qaadi karta isku-midnaanta natiijooyinka mustaqbalka.

 

Helitaanka Noocyada-hoosaadka Homogenous

 

Marka la eego xulashada biomarker, baalal badan ayaa laga yaabaa in loo baahdo dariiqooyin kala duwan oo suurtagal ah oo cilmi-baaristu ay saameyn karto. Isku soo wada duuboo, caddaymaha hadda jira waxay muujinayaan in astaamaha biomarker ay hubaal yihiin, laakiin ay si buuxda u beddeleen tiro hoose oo shakhsiyaad ah oo hadda la ildaran niyad-jabka. Tan waxa laga yaabaa in lagu aasaaso gudaha ama guud ahaan qaybaha ogaanshaha, taas oo u xisaabin doonta waxoogaa iswaafaqla'aan ah natiijooyinka lagu arki karo suugaantan. Tirinta koox-hoosaadyada bayoolojiga (ama koox-hoosaadyada) waxa si wax ku ool ah u fududayn kara falanqayn kooxeedyo badan oo shabakadaha biomarker-ka ee niyad-jabka. Tani waxay tusinaysaa kala duwanaanshaha dadka dhexdiisa; Falanqaynta fasalka qarsoon waxay soo bandhigi kartaa astaamo caafimaad oo kala duwan oo ku saleysan, tusaale ahaan, caabuq.

 

Saamaynta daawaynta gaarka ah ee bararka iyo jawaabta

 

Dhammaan daawaynta sida caadiga ah loo qoro ee niyad-jabka waa in si guud loo qiimeeyaa saameyntooda bayooloji ee gaarka ah, sidoo kale waxaa lagu xisaabtamayaa waxtarka tijaabooyinka daawaynta. Tani waxay awood u siin kartaa dhismayaal la xidhiidha biomarkers iyo bandhigyada calaamadaha si loo saadaaliyo natiijooyinka kala duwan ee daawaynta ka hortagga niyad-jabka ee qaab shakhsiyeysan, waxaana laga yaabaa inay suurtogal tahay marka la eego macnaha guud ee niyad-jabka midpolar iyo laba-cirifoodka. Tani waxay u badan tahay inay faa'iido u leedahay daawaynta cusub ee suurtagalka ah iyo sidoo kale daawaynta hadda la tilmaamay.

 

Go'aaminta Mustaqbalka ee Jawaabta Daaweynta

 

Isticmaalka farsamooyinka kor ku xusan waxay u badan tahay inay keento karti la wanaajiyey si loo saadaaliyo caabbinta daaweynta si la filayo. Tallaabooyin dhab ah oo joogto ah (tusaale, muddada-dheer) ee jawaab-celinta daawaynta ayaa wax ku kordhin karta tan. Qiimaynta qiyaasaha kale ee saxda ah ee fayo-qabka bukaanka (sida tayada nolosha iyo shaqada maalinlaha ah) waxay bixin kartaa qiimeyn dhamaystiran oo natiijada daaweynta taas oo laga yaabo inay si dhow ula xiriirto biomarkers. Iyadoo dhaqdhaqaaqa bayoolojiga oo keliya laga yaabo in aanay kala saari karin jawaab-bixiyeyaasha daawaynta iyo kuwa aan jawaab-celinta lahayn, cabbiraadaha is-daba-joogga ah ee biomarkers ee leh doorsoomayaal nafsiyeed ama bulsho ayaa lagu dhex dari karaa macluumaadka biomarker si loo horumariyo qaabka saadaalinta ee jawaab-celinta daaweynta aan ku filnayn. Haddii qaab la isku halayn karo la sameeyo si loo saadaaliyo jawaabta (ha ahaato dadka niyad-jabsan ama dad hoosaadyo) oo dib loo ansixiyo, nakhshad tarjumaad ayaa xaqiijin karta ku-dhaqankeeda tijaabo weyn oo la kantaroolo.

 

Xagga Daawaynta Habboon

 

Waqtigan xaadirka ah, bukaanada qaba niyad-jabka si nidaamsan looguma jiheeyo si ay u helaan barnaamij wax qabad oo la hagaajiyay. Haddii la ansixiyo, nakhshad tijaabo ah ayaa la adeegsan karaa si loo tijaabiyo moodal si loo saadaaliyo jawaab-la'aan iyo/ama si loo go'aamiyo halka uu bukaanku u baahan yahay in lagu kala sooco qaab daryeel oo la talaabsaday. Tani waxay faa'iido u yeelan kartaa labadaba goobaha daaweynta caadiga ah iyo kuwa caadiga ah, ee noocyada kala duwan ee faragelinta. Ugu dambayntii, qaab caafimaad ahaan la samayn karo ayaa la samayn karaa si loo siiyo shakhsiyaadka daawaynta ugu habboon, si loo aqoonsado kuwa ay u badan tahay inay yeeshaan niyad-jabka iyo inay siiyaan daryeel iyo la-socod la xoojiyey bukaannadaas. Bukaannada loo aqoonsaday inay halis ugu jiraan iska caabbinta daawaynta ayaa laga yaabaa in loo qoro daawaynta cilmi nafsiga iyo farmashiyeedka ee isku xidhan ama dawooyinka dawooyinka la isku daray. Tusaale ahaan, ka-qaybgalayaasha aan lahayn kor u kaca cytokine proinflammatory waxaa laga yaabaa in lagu tilmaamo inay helaan cilmi nafsi halkii ay ka heli lahaayeen daaweynta farmashiyaha, halka qayb ka mid ah bukaannada qaba caabuqa sare ee gaar ahaan ay heli karaan wakiilka anti-bararka ee kordhinta daaweynta caadiga ah. Si la mid ah shaandhaynta, xeeladaha xulashada daawaynta shakhsi ahaaneed ayaa suurtogal ah mustaqbalka. Tusaale ahaan, qof gaar ah oo niyad-jabsan ayaa laga yaabaa inuu lahaa TNF aad u sareysa? heerarka, laakiin ma jiraan cillado kale oo bayooloji ah, oo laga yaabaa in laga faa'iidaysto daawaynta muddada gaaban ee TNF? antagonist.54 Daawaynta shakhsi ahaaneed waxay sidoo kale keeni kartaa la socodka muujinta biomarker inta lagu jiro daawaynta si loo ogeysiiyo isbeddelada dhexgalka ee suurtogalka ah, dhererka daaweynta joogtada ah ee loo baahan yahay ama si loo ogaado calaamadaha hore ee soo noqoshada.

 

Bartilmaameedyada Daawaynta Cusub

 

Waxaa jira tiro badan oo daweyn oo suurtagal ah oo waxtar u yeelan kara niyad-jabka, kuwaas oo aan si ku filan loo baarin, oo ay ku jiraan waxqabadyo cusub ama dib loo soo celiyay oo ka yimid qaybaha kale ee caafimaadka. Qaar ka mid ah bartilmaameedyada ugu caansan ayaa ku jiray daawooyinka anti-bararka sida celecoxib (iyo cyclooxygenase-2 inhibitors kale), TNF? antagonists etanercept iyo infliximab, minocycline ama aspirin. Kuwani waxay u muuqdaan kuwo rajo leh.178 Xeryaha Antiglucocorticoid, oo ay ku jiraan ketoconazole179 iyo metyrapone,180 ayaa lagu baaray niyad-jabka, laakiin labaduba waxay leeyihiin dib-u-dhacyo leh muuqaalkooda saameyntooda iyo awoodda bukaan-socodka ee metyrapone waa mid aan la hubin. Mifepristone181 iyo corticosteroids fludrocortisone iyo spironolactone,182 iyo dexamethasone iyo hydrocortisone183 waxa kale oo laga yaabaa inay waxtar u yeeshaan daawaynta niyad-jabka muddada gaaban. Bartilmaameedka glutamate N-methyl-d-aspartate antagonists, oo ay ku jiraan ketamine, ayaa laga yaabaa inay matalaan daawaynta waxtarka leh ee niyad-jabka.184 Omega-3 polyunsaturated fatty acids waxay saameeyaan bararka iyo dhaqdhaqaaqa dheef-shiid kiimikaadka waxayna u muuqdaan inay muujinayaan waxtarka niyad-jabka.185 Waa suurtogal in statins laga yaabo in waxay leeyihiin saameyn lid ku ah niyad-jabka186 iyada oo loo marayo waddooyinka neurobiological ee khuseeya.187

 

Sidan, saamaynta bayoloji ee dawooyinka lidka diiqadda (eeg qaybta daawaynta) ayaa loo isticmaalay faa'iidooyinka kiliinikada ee qaybaha kale: gaar ahaan gastroenterological, neurologic iyo xanuunnada calaamadaha aan khaaska ahayn. faa'iidooyinkan. Lithium ayaa sidoo kale la soo jeediyay in la yareeyo bararka, si aad ah iyada oo loo marayo glycogen synthase kinase-188.

 

Dr-Jimenez_White-Coat_01.png

Dr. Alex Jimenez's Insight

Niyad-jabka waa cillad caafimaadka maskaxda oo lagu garto calaamado daran oo saameeya niyadda, oo ay ku jiraan luminta xiisaha hawlaha. Daraasadihii ugu dambeeyay ee cilmi-baarista, si kastaba ha ahaatee, waxay ogaadeen in laga yaabo inay suurtogal tahay in lagu ogaado niyad-jabka iyada oo la adeegsanayo wax ka badan oo kaliya calaamadaha dabeecadda bukaanka. Sida laga soo xigtay cilmi-baarayaashu, ogaanshaha si sahlan loo heli karo biomarkers kuwaas oo si sax ah u ogaan kara niyad-jabka ayaa aasaas u ah hagaajinta caafimaadka guud ee bukaanka iyo fayoobaanta. Tusaale ahaan, natiijooyinka kiliinikada waxay soo jeedinayaan in shakhsiyaadka qaba xanuunka weyn ee niyad-jabka, ama MDD, ay leeyihiin heerar hoose oo ah molecule acetyl-L-carnitine, ama LAC, ee dhiiggooda marka loo eego kontaroolada caafimaadka leh. Ugu dambeyntii, samaynta biomarkers ee niyad-jabka waxay suurtogal u tahay inay si fiican u go'aamiso cidda khatarta ugu jirta inuu ku dhaco xanuunka iyo sidoo kale caawinta xirfadlayaasha daryeelka caafimaadka inay go'aamiyaan ikhtiyaarka daaweynta ugu fiican ee bukaanka qaba niyad-jabka.

 

Ugu Dambeyn

 

Suugaantu waxay tilmaamaysaa in ku dhawaad ​​saddex-meelood laba meel bukaanada qaba niyad-jabka aanay ku guulaysan daawaynta bilowga ah iyo in suurtogalnimada jawaab-la'aantu ay korodho tirada daawaynta ee la tijaabiyay. Bixinta daawaynta aan waxtarka lahayn waxay leedahay cawaaqib xumo qofka iyo kharashka bulshada, oo ay ku jiraan murugo joogto ah iyo fayoobid liidata, khatarta is-dilka, luminta wax soo saarka iyo agabka daryeelka caafimaadka ee khasaaray. Suugaanta baaxadda leh ee ku jirta buufiska ayaa tilmaamaya tiro aad u badan oo biomarkers ah oo awood u leh inay hagaajiyaan daaweynta dadka niyad-jabka qaba. Marka lagu daro calaamadaha neurotransmitter iyo neuroendocrine kuwaas oo lagu soo rogay daraasad ballaaran muddo tobanaan sano ah, aragtiyihii dhawaa waxay muujinayaan jawaabta bararka (iyo habka difaaca jirka guud ahaan), dheef-shiid kiimikaadka iyo korriinka sida muhiimka ah ee ku lug leh niyad-jabka. Si kastaba ha ahaatee, caddaymaha xad-dhaafka ah ee ka soo horjeeda ayaa muujinaya in ay jiraan tiro caqabado ah oo u baahan in wax laga qabto ka hor intaan cilmi-baarista biomarker aan la isticmaalin si loo hagaajiyo maamulka iyo daryeelka dadka qaba niyad-jabka. Sababtoo ah kakanaanta nidaamyada bayoolojiga, baaritaanada isku mar ah ee calaamado kala duwan oo muunado waaweyn ah ayaa faa'iido weyn u leh helitaanka isdhexgalka ka dhexeeya bayoolojiga iyo dawladaha nafsiga ah ee shakhsiyaadka. Wanaajinta cabbiraadda labada cabbir neurobiological iyo cabbirada bukaan-socodka ee niyad-jabka waxay u badan tahay inay fududayso faham weyn. Dib u eegistani waxay sidoo kale muujinaysaa muhiimada ay leedahay in la baaro arrimo wax ka bedeli kara (sida jirro, da'da, garashada iyo daawaynta) marka la ururiyo fahamka isku xidhan ee bayoolajiga niyad-jabka iyo hababka iska caabbinta daaweynta. Waxay u badan tahay in calaamadaha qaar ay muujin doonaan ballanqaadka ugu badan ee saadaalinta jawaabta daaweynta ama iska caabinta daawaynta gaarka ah ee koox-hoosaadka bukaanada, iyo cabbiraadda isku-dhafka ah ee xogta nafleyda iyo cilmi-nafsiga waxay kor u qaadi kartaa awoodda si loo aqoonsado kuwa halista ugu jira natiijooyinka daaweynta liidata. Samaynta guddi biomarker waxay saamayn ku leedahay kor u qaadista saxnaanta ogaanshaha iyo saadaasha, iyo sidoo kale daawaynta shaqsiyaynta marxaladda ugu horraysa ee jirada niyad-jabka iyo horumarinta yoolalka daawaynta cusub ee waxtarka leh. Saamayntan ayaa laga yaabaa inay ku koobnaadaan kooxo-hoosaadyada bukaanka niyad-jabsan. Dariiqooyinka loo maro fursadahan ayaa dhamaystiraya xeeladaha cilmi-baarista ee dhawaanahan si loogu xiro cilladaha kiliinikada si aad ugu dhow si ay ugu dhow yihiin substrate-ka neerfaha. Way caddahay in inkasta oo shaqo badan loo baahan yahay, samaynta xidhiidhka ka dhexeeya biomarkers ee khuseeya iyo xanuunada niyad-jabka ayaa saameyn weyn ku leh dhimista culayska niyad-jabka ee heer shakhsi iyo bulsho.

 

Mahadnaq

 

Warbixintani waxay matalaysaa cilmi-baadhis madax-banaan oo uu maalgeliyay Machadka Qaranka ee Cilmi-baadhista Caafimaadka (NIHR) Xarunta Cilmi-baarista Biomedical ee Koonfurta London iyo Maudsley NHS Foundation Trust iyo King College London. Aragtiyada la soo bandhigay waa kuwa qorayaasha ee maahan kuwa NHS, NIHR ama Waaxda Caafimaadka.

 

Qoraalada

 

Shaacinta AHY wuxuu 3dii sano ee la soo dhaafay ku helay maamuus ka hadalka Astra Zeneca (AZ), Lundbeck, Eli Lilly, Sunovion; sharafta la-talinta Allergan, Livanova iyo Lundbeck, Sunovion, Janssen; iyo taageerada deeqda cilmi-baarista ee Janssen iyo hay'adaha maalgelinta UK (NIHR, MRC, Wellcome Trust). AJC waxay 3-dii sano ee la soo dhaafay heshay sharaf ay ku hadasho Astra Zeneca (AZ), sharaf latalinta Allergan, Livanova iyo Lundbeck, iyo taageerada deeqda cilmi baarista ee Lundbeck iyo wakaaladaha maalgalinta UK (NIHR, MRC, Wellcome Trust).

 

Qorayaashu ma soo sheegaan khilaafyo kale oo xiiso leh oo ku saabsan shaqadan.

 

Gabagabadii,Iyadoo cilmi-baarisyo badan oo cilmi-baaris ah ay heleen boqolaal biomarkers oo loogu talagalay niyad-jabka, qaar badan maahan kuwo aasaasay doorkooda xanuunka niyad-jabka ama sida saxda ah ee macluumaadka bayoolojiga looga faa'iidaysan karo si kor loogu qaado ogaanshaha, daaweynta iyo saadaalinta. Si kastaba ha noqotee, maqaalka kor ku xusan wuxuu dib u eegayaa suugaanta la heli karo ee biomarkers ee ku lug leh inta lagu jiro hababka kale waxayna isbarbardhigaan natiijooyinka bukaan-socodka iyo kuwa niyad-jabka. Intaa waxaa dheer, natiijooyinka cusub ee biomarkers ee niyad-jabka ayaa laga yaabaa inay si fiican u caawiyaan in si fiican loo baaro niyad-jabka si loola socdo daaweyn wanaagsan. Macluumaadka laga soo xigtay Xarunta Qaranka ee Macluumaadka Bayolojiyada (NCBI) Si aad ugala hadasho mawduuca, fadlan xor u noqo inaad waydiiso Dr. Jimenez ama nagala soo xidhiidh at�915-850-0900 .

 

Waxaa soo saaray Dr. Alex Jimenez

 

Green-Call-Now-Button-24H-150x150-2-3.png

 

Mawduucyo Dheeraad ah: Xanuunka Dhabarka

Xanuunka dhabarka waa mid ka mid ah sababaha ugu badan ee naafanimada iyo maalmaha shaqada laga waayo adduunka oo dhan. Sida xaqiiqda ah, xanuunka dhabarka ayaa loo aaneynayaa inuu yahay sababta labaad ee ugu badan ee booqashooyinka xafiiska dhakhtarka, oo ka badan kaliya caabuqyada neef-mareenka sare. Qiyaastii 80 boqolkiiba dadku waxay la kulmi doonaan nooc ka mid ah xanuunka dhabarka ugu yaraan hal mar noloshooda oo dhan. Laf-dhabarta waa qaab dhismeed kakan oo ka kooban lafo, kala-goysyo, seedaha iyo murqaha, iyo unugyo kale oo jilicsan. Taas awgeed, dhaawacyada iyo/ama xaaladaha sii xumeeyay, sida maqaarka herniated, ugu dambeyntii waxay keeni kartaa calaamadaha xanuunka dhabarka. Dhaawacyada isboortiga ama dhaawacyada shilalka baabuurta ayaa inta badan ah sababta ugu badan ee xanuunka dhabarka, si kastaba ha ahaatee, mararka qaarkood dhaqdhaqaaqa ugu fudud ayaa keeni kara natiijooyin xanuun leh. Nasiib wanaag, xulashooyinka daaweynta kale, sida daryeelka xanuunka loo yaqaan 'chiropractic care', ayaa kaa caawin kara yareynta xanuunka dhabarka iyada oo loo marayo isticmaalka isbeddelka laf-dhabarka iyo manfacyada gacanta, ugu dambeyntii hagaajinta xanuunka.

 

 

 

sawir blog of kartoon paperboy war weyn

 

 

MAWDUUC DHEERAAD AH OO MUHIIM AH: Maareynta Xanuunka Dhabarka Hoose

 

Mawduucyo intaa ka badan: DHEERAAD AH: Xanuun & Daawayn Raaag ah

 

Blank
tixraacyada
1.�Prince M, Patel V, Saxena S, iyo al. Ma jiro caafimaad la'aan caafimaadka maskaxda.�Lancet.�2007;370(9590):859�877.[PubMed]
2.�Kingdon D, Wykes T. Maalgelinta la kordhiyay ee loo baahan yahay cilmi-baarista caafimaadka dhimirka.�BMJ.�2013;346:f402.[PubMed]
3.�Vivekanantham S, Strawbridge R, Rampuri R, Ragunathan T, Young AH. Sinaanta daabacaadda ee cilmi nafsiga.�Br J Dhimirka2016;209(3):257�261.�[PubMed]
4.�Fava M. ogaanshaha iyo qeexida niyad-jabka u adkaysta daaweynta.�Biol dhimirka.�2003;53(8):649�659.�[PubMed]
5.�Insel T, Cuthbert B, Garvey M, iyo al. Shuruudaha domainka cilmi baarista (RDoC): dhanka qaab-dhismeedka cusub ee kala soocida cilmi baarista xanuunada dhimirka.�Waxaan ahay J maskaxiyan.�2010;167(7):748�751.�[PubMed]
6.�Kapur S, Phillips AG, Insel TR. Waa maxay sababta ay waqti dheer u qaadatay cilmi-nafsiga nafleyda si uu u sameeyo baaritaanno caafimaad iyo waxa laga sameeyo.�Mol dhimirka.�2012;17(12):1174�1179.�[PubMed]
7.�Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush JA. Maxaa STAR*D na baray? Natiijooyinka ka soo baxay tijaabo baaxad leh, la taaban karo, oo bukaan-socod ah oo loogu talagalay bukaanada qaba niyad-jabka.�Adeegga Cilmi-nafsiga.�2009;60(11):1439�1445.�[PubMed]
8.�Fekadu A, Rane LJ, Wooderson SC, Markopoulou K, Poon L, Cleare AJ. Saadaasha natiijada mustaqbalka fog ee niyad-jabka u adkaysta daawaynta ee daryeelka jaamacadeed.�Br J Dhimirka2012;201(5):369�375.[PubMed]
9.�Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ. Maxaa ku dhacaya bukaanada qaba niyad-jabka u adkaysta? Dib-u-eegis habaysan oo lagu sameeyo daraasadaha natiijada muddada dhexe iyo kuwa fog.�J Saamaynta Dhibaatada.�2009;116(1�2):4�11.�[PubMed]
10.�Trivedi M. Xeeladaha daawaynta si loo horumariyo loona joogteeyo cafiska xanuunka weyn ee niyad jabka.�Dialogues Clin Neurosci.�2008;10(4):377.�[Maqaallo bilaash ah PMC] [PubMed]
11.�Fekadu A, Wooderson SC, Markopoulou K, Cleare AJ. Habka Maudsley Staging ee loogu talagalay niyad-jabka u adkeysiga daaweynta: saadaalinta natiijada muddada dheer iyo joogteynta calaamadaha.J Clin waa dhakhtarka dhimirka2009;70(7):952�957.�[PubMed]
12.�Bennabi D, Aouizerate B, El-Hage W, iyo al. Qodobbada halista u ah iska caabbinta daawaynta ee niyad-jabka hal-xiran: dib-u-eegis habaysan.�J Saamaynta Dhibaatada.�2015;171:137�141.�[PubMed]
13.�Serretti A, Olgiati P, Liebman MN, iyo al. Saadaasha bukaan-socodka ee jawaab-celinta niyad-jabka ee cilladaha niyadda: moodooyinka shabakadaha kala duwan ee tooska ah iyo kuwa neerfaha.�Cilmi-nafsiga Cilmi-nafsiga2007;152(2�3):223�231.[PubMed]
14.�Driessen E, Hollon SD. Daaweynta dabeecadda garashada ee xanuunka niyadda: waxtarka, dhexdhexaadiyeyaasha iyo dhexdhexaadiyeyaasha.�Dhakhtarka maskaxda ee Clin North Am.�2010;33(3):537�555.�[Maqaallo bilaash ah PMC] [PubMed]
15.�Cleare A, Pariante C, Young A, iyo al. Xubnaha Shirka Consensus Consensus Tilmaamaha ku salaysan daawaynta ciladaha niyad-jabka leh dawooyinka niyad-jabka: dib u eegis lagu sameeyay ururka Ingiriiska ee 2008 ee tilmaamaha cilmi nafsiga.�J Psychopharmacol.�2015;29(5):459�525.�[PubMed]
16.�Tunnard C, Rane LJ, Wooderson SC, iyo al. Saamaynta dhibka caruurnimo ee isdilka iyo koorsada kiliinikada ee niyad-jabka u adkaysta daawaynta.�J Saamaynta Dhibaatada.�2014;152 154:122�130.�[PubMed]
17.�Nemeroff CB, Heim CM, Thase ME, iyo al. Jawaabaha kala duwan ee teraabiyada cilminafsiga iyo daawaynta farmashiyaha ee bukaanada qaba qaababka dabadheeraada ee niyad-jabka weyn iyo dhaawaca caruurnimada.Proc Natl Acad Sci US A.�2003;100(24):14293�14296.�[Maqaallo bilaash ah PMC] [PubMed]
18.�Nierenberg AA. Saadaasha jawaabta daawoyinka niyad-jabka ee mabaadi'da guud iyo saamaynta bukaan-socodka.�Dhakhtarka maskaxda ee Clin North Am.�2003;26(2):345�352.�[PubMed]
19.�Igu waa. Isticmaalka biomarkers si loo saadaaliyo jawaabta daaweynta xanuunka weyn ee niyad-jabka: caddaynta daraasadihii hore iyo kuwa hadda jira.�Dialogues Clin Neurosci.�2014;16(4):539�544.�[Maqaallo bilaash ah PMC] [PubMed]
20.�Jani BD, McLean G, Nicholl BI, iyo al. Qiimaynta khatarta ah iyo saadaalinta natiijooyinka bukaannada qaba calaamadaha niyad-jabka: dib-u-eegis lagu sameeyo doorka suurtagalka ah ee biomarkers ku salaysan dhiigga durugsan.Hore ee Hum Neurosci.�2015;9:18.[Maqaallo bilaash ah PMC] [PubMed]
21.�Suravajhala P, Kogelman LJ, Kadarmideen HN. Is dhexgalka iyo falanqaynta xogta Multi-omic iyadoo la adeegsanayo hababka genomics hababka: hababka iyo codsiyada wax soo saarka xoolaha, caafimaadka iyo daryeelka.�Genet Sel Evol2016;48(1):1.�[Maqaallo bilaash ah PMC] [PubMed]
22.�Menke A. Muujinta Hiddaha: Biomarker of the antidepressant therapy?�Int Rev Psychiatry.�2013;25(5):579�591.�[PubMed]
23.�Peng B, Li H, Peng XX. Dheef-shiid kiimikaad shaqeynaya: laga soo bilaabo baadhista biomarker ilaa dib-u-habaynta dheef-shiid kiimikaadka.�Unugyada Protein-ka.�2015;6(9):628�637.�[Maqaallo bilaash ah PMC] [PubMed]
24.�Aagaard K, Petrosino J, Keitel W, et al. Istaraatiijiyada Mashruuca Microbiome ee Human Microbiome ee muunad dhammaystiran ee microbiome-ka aadanaha iyo sababta ay muhiim u tahay.FASEB J.�2013;27(3):1012�1022.[Maqaallo bilaash ah PMC] [PubMed]
25.�Sonner Z, Wilder E, Heikenfeld J, iyo al. Microfluidics-ka qanjidhada dhididka eccrine, oo ay ku jiraan qaybinta biomarker, gaadiidka, iyo saamaynta biosensing.�Biomicrofluidics2015;9(3): 031301.[Maqaallo bilaash ah PMC] [PubMed]
26.�Schmidt HD, Shelton RC, Duman RS. biomarkers functional of niyad-jabka: ogaanshaha, daaweynta, iyo pathophysiology.�Neuropsychopharm2011;36(12):2375�2394.�[Maqaallo bilaash ah PMC] [PubMed]
27.�J Brand S, Moller M, H Harvey B. Dib u eegis lagu sameeyay biomarkers ee niyadda iyo xanuunada nafsiga ah: kala qaybinta bukaan-socodka iyo isku-xirnaanta hore.�Curr Neuropharmacol.�2015;13(3):324�368.[Maqaallo bilaash ah PMC] [PubMed]
28.�Lopresti AL, Sameeyaha GL, Hood SD, Drummond PD. Dib-u-eegis lagu sameeyo biomarkers-ka durugsan ee niyad-jabka weyn: awoodda bararka iyo walbahaarka nooleyaasha.Prog Neuropsychopharmacol Biol Psychiatry.�2014;48:102�111.�[PubMed]
29.�Fu CH, Steiner H, Costafreda SG. biomarkers neural ee saadaaliya ee jawaabta kiliinikada ee niyad-jabka: falanqayn-meta ee daraasadaha neuroimaging functional iyo qaab-dhismeedka ee daaweynta dawooyinka iyo cilmi nafsiga.Neurobiol Dis. �2013;52:75�83.�[PubMed]
30.�Mamdani F, Berlim M, Beaulieu M, Labbe A, Merette C, Turecki G. Gene muujinta biomarkers ee jawaabta daawaynta citalopram ee xanuunka murugada weynTransl Maskaxda.�2011;1(6): e13.[Maqaallo bilaash ah PMC] [PubMed]
31.�Smith RS. Aragtida makrophage ee niyad-jabka.�Med mala awaal.�1991;35(4):298�306.�[PubMed]
32.�Irwin MR, Miller AH. Xanuunada niyad-jabka ah iyo difaaca: 20 sano oo horumar iyo daahfurid ah.�Dabeecada maskaxda ee difaaca jirka.�2007;21(4):374�383.�[PubMed]
33.�Maes M, Leonard B, Myint A. Triptophan catabolites (TRYCATs), labaduba waxay gacan ka geystaan ​​bilawga niyad-jabka.Prog Neuropsychopharmacol Biol Psychiatry.�2011;35(3):702�721.[PubMed]
34.�Miller AH, Maletic V, Raison CL. Caabuqa iyo xumaantiisa: Doorka cytokines ee cilmi-nafsiga cilmi-nafsiga ee niyad-jabka weyn.Biol dhimirka.�2009;65(9):732�741.�[Maqaallo bilaash ah PMC] [PubMed]
35.�Miller AH, Raison CL. Doorka caabuqa ee niyad-jabka: laga bilaabo lama huraanka korriinka ilaa bartilmaameedka daawaynta casriga ah.�Nat Rev Immun.�2016;16(1):22�34.�[Maqaallo bilaash ah PMC] [PubMed]
36.�Raison CL, Capuron L, Miller AH. Cytokines waxay heestaan ​​blues: bararka iyo cudur-sidaha niyad-jabka.�Trends Immun.�2006;27(1):24�31.�[Maqaallo bilaash ah PMC] [PubMed]
37.�Raison CL, Felger JC, Miller AH. Caabuqa caabuqa iyo daawaynta ee niyad-jabka weyn: duufaanka ugu fiican.�Maskaxda Times.2013;30(9)
38.�Dowlati Y, Herrmann N, Swardfager W, iyo al. Falanqaynta maadada cytokines ee niyad-jabka weyn.�Biol dhimirka.�2010;67(5):446�457.�[PubMed]
39.�Eyre HA, Air T, Pradhan A, iyo al. Falanqaynta maadada-chemokines ee niyad-jabka weyn.�Prog Neuropsychopharmacol Biol Psychiatry.�2016;68:1�8.�[Maqaallo bilaash ah PMC] [PubMed]
40.�Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimki M. Falanqaynta meta-falanqaynta interleukins 6 iyo 1?, factor necrosis tumor ? iyo borotiinka C-reactive ee bukaanka qaba xanuunka weyn ee niyad-jabka.�Dabeecada maskaxda ee difaaca jirka.�2015;49:206�215.�[Maqaallo bilaash ah PMC] [PubMed]
41.�Howren MB, Lamkin DM, Suls J. Ururada niyad-jabka ee leh borotiinka C-reactive, IL-1, iyo IL-6: falanqayn meta.�Psychosom Med.�2009;71(2):171�186.�[PubMed]
42.�Liu Y, Ho RC-M, Mak A. Interleukin (IL) -6, buro necrosis factor alpha (TNF-?) iyo interleukin-2 reseptors (sIL-2R) ayaa kor loogu qaaday bukaanka qaba xanuunka weyn ee niyad-jabka: meta- falanqaynta iyo dib-u-celinta-meta.�J Saamaynta Dhibaatada.�2012;139(3):230�239.�[PubMed]
43.�Strawbridge R, Arnone D, Danish A, Papadopoulos A, Herane Vives A, Cleare AJ. Caabuqa iyo jawaab-celinta bukaan-socodka ee daaweynta niyad-jabka: falanqayn-meta.�Eur Neuropsychopharmacol.�2015;25(10):1532�1543.�[PubMed]
44.�Farooq RK, Asghar K, Kanwal S, Zulqernain A. Doorka cytokines bararka ee niyad-jabka: Diirada saar interleukin-1? (Dib u eegis)�Biomed Rep.�2017;6(1):15�20.�[Maqaallo bilaash ah PMC] [PubMed]
45.�Cattaneo A, Ferrari C, Uher R, iyo al. Cabbirrada saxda ah ee hijrada macrophage inhibitory factor iyo interleukin-1-? Heerarka mRNA waxay si sax ah u saadaaliyaan jawaabta daawaynta ee bukaanka niyad jabsan.�Int J Neuropsychopharmacol2016;19(10):pyw045.�[Maqaallo bilaash ah PMC] [PubMed]
46.�Baune B, Smith E, Reppermund S, iyo al. Biomarkers bararka waxay saadaaliyaan calaamadaha niyad-jabka, laakiin maaha walaaca xilliga da'da: xusuusta mustaqbalka ee Sydney iyo daraasadda gabowga.Psychoneuroendocrinol2012;37(9):1521�1530.�[PubMed]
47.�Fornaro M, Rocchi G, Escelsior A, Contini P, Martino M. Waxaa laga yaabaa in isbeddellada cytokine ee kala duwan ee bukaannada niyad-jabsan ee qaata duloxetine ay muujinayaan asal nololeed oo kala duwan.J Saamaynta Dhibaatada.�2013;145(3):300�307.�[PubMed]
48.�Hernandez ME, Mendieta D, Martinez-Fong D, iyo al. Kala duwanaanshaha wareegga wareegga heerarka cytokine inta lagu jiro koorsada 52 toddobaad ee daaweynta SSRI ee xanuunka weyn ee niyad-jabka.Eur Neuropsychopharmacol.�2008;18(12):917�924.�[PubMed]
49.�Hannestad J, DellaGioia N, Bloch M. Saamaynta daawaynta daawoyinka lidka diiqadda ee heerarka serum ee cytokines bararka: falanqaynta meta.�Neuropsychopharmacology.�2011;36(12):2452�2459.[Maqaallo bilaash ah PMC] [PubMed]
50.�Hiles SA, Atia J, Baker AL. Isbeddellada interleukin-6, borotiinka C-reactive iyo interleukin-10 ee dadka niyad-jabka leh ka dib daawaynta lidka diiqada: Falanqaynta meta.�Brain Behav Immun; Waxaa lagu soo bandhigay: Kulanka Sannadlaha ah ee 17aad ee Bulshada Cilmi-baarista Cilmi-nafsiga NeuroImmunology PsychoNeuroImmunology: Ka Gudbinta Anshaxa La-dagaalanka Cudurka; 2012. p. S44.
51.�Harley J, Luty S, Carter J, Mulder R.J Psychopharmacol.�2010;24(4):625�626.�[PubMed]
52.�Uher R, Tansey KE, Dew T, iyo al. Biomarker bararka sida saadaaliya kala duwanaanshaha natiijada daaweynta niyad-jabka ee escitalopram iyo nortriptyline.�Waxaan ahay J maskaxiyan.�2014;171(2):1278�1286.[PubMed]
53.�Chang HH, Lee IH, Gean PW, iyo al. Jawaabta daawaynta iyo daciifnimada garashada ee niyad-jabka weyn: Ururka leh borotiinka C-reactive.�Dabeecada maskaxda ee difaaca jirka.�2012;26(1):90�95.�[PubMed]
54.�Raison CL, Rutherford RE, Woolwine BJ, iyo al. Tijaabo aan kala sooc lahayn oo la kantaroolay oo ah buro necrosis factor antagonist infliximab ee niyad-jabka u adkaysta: doorka aasaasiga ah ee biomarkers bararka.Cilmi-nafsiga JAMA2013;70(1):31�41.�[Maqaallo bilaash ah PMC] [PubMed]
55.�Krishnadas R, Cavanagh J. Niyad-jab: xanuun barar ah?�J Neurol Neurosurg Maskaxda2012;83(5):495�502.�[PubMed]
56.�Raison CL, Miller AH. Niyad-jabku ma yahay xanuunka caabuqa?�Curr Psychiatry Rep.�2011;13(6):467�475.�[Maqaallo bilaash ah PMC] [PubMed]
57.�Simon N, McNamara K, Chow C, iyo al. Baaritaan faahfaahsan oo ku saabsan cilladaha cytokine ee xanuunka weyn ee niyad-jabka.�Eur Neuropsychopharmacol.�2008;18(3):230�233.�[Maqaallo bilaash ah PMC] [PubMed]
58.�Dahl J, Ormstad H, Aass HC, iyo al. Heerarka balasmaha ee cytokines kala duwan ayaa kor u kaca inta lagu jiro niyad-jabka socda waxaana hoos loo dhigaa heerar caadi ah ka dib soo kabashadaPsychoneuroendocrinol2014;45:77�86.�[PubMed]
59.�Stelzhammer V, Haenisch F, Chan MK, iyo al. Isbeddellada borotiinka ee serum bilawga ugu horreeya, daawada niyad-jabka - oo aan lahayn bukaanka niyad-jabka weyn.Int J Neuropsychopharmacol2014;17(10):1599�1608.�[PubMed]
60.�Liu Y, HO RCM, Mak A. Doorka interleukin (IL-17) ee walaaca iyo niyad-jabka bukaanka qaba rheumatoid arthritis-ka.Int J Rheum Dis. �2012;15(2):183�187.�[PubMed]
61.�Diniz BS, Sibille E, Ding Y, iyo al. Calaamadaha noolaha ee Plasma iyo pathology-ga maskaxda ee la xidhiidha garasho la'aanta joogtada ah ee niyad-jabka nolosha dambe.Mol dhimirka.�2015;20(5):594�601.�[Maqaallo bilaash ah PMC][PubMed]
62.�Janelidze S, Ventorp F, Erhardt S, iyo al. Heerarka chemokine ee dheecaanka cerebrospinal iyo balasmaha ee isku dayada isdilka ah oo isbedelay.�Psychoneuroendocrinol2013;38(6):853�862.�[PubMed]
63.�Powell TR, Schalkwyk LC, Heffernan AL, iyo al. Faa'iidada necrosis ee burada iyo bartilmaameedyadeeda dariiqa cytokine bararka ayaa loo aqoonsaday inay yihiin biomarkers transcriptomic-ka-saarista ee jawaabta escitalopram.Eur Neuropsychopharmacol.�2013;23(9):1105�1114.�[PubMed]
64.�Wong M, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms ee hidde-sideyaasha caabuqa waxay la xidhiidhaan u nuglaanshaha niyad-jabka weyn iyo jawaab-celinta niyad-jabka.Mol dhimirka.�2008;13(8):800�812.�[Maqaallo bilaash ah PMC] [PubMed]
65.�Kling MA, Alesci S, Csako G, iyo al. Joogtaynta heerka hoose ee pro-bararka ee aan la daawayn, haweenka la cafiyay ee qaba xanuunka weyn ee niyad-jabka sida lagu caddeeyey heerarka serum oo sarreeya ee borotiinnada wejiga ba'an ee borotiinka C-reactive iyo serum amyloid A.�Biol dhimirka.�2007;62(4):309�313.�[Maqaallo bilaash ah PMC][PubMed]
66.�Schaefer M. Sarkar S. Schwarz MNeuropsychobiol �2016;74(1):8�14.[PubMed]
67.�Dimopoulos N, Piperi C, Salonicioti A, iyo al. Kor u qaadista fiirsashada balaasmaha ee unugyada adhesionka ee niyad-jabka nolosha dambe.�Int J Geriatr dhimirka.�2006;21(10):965�971.�[PubMed]
68.�Bocchio-Chiavetto L, Bagnardi V, Zanardini R, iyo al. Serum iyo Plasma Heerarka BDNF ee niyad-jabka weyn: daraasad ku-noqosho iyo falanqayn-meta.�World J Biol Psychiatry.�2010;11(6):763�773.�[PubMed]
69.�Brunoni AR, Lopes M, Fregni FInt J Neuropsychopharmacol2008;11(8):1169�1180.�[PubMed]
70.�Molendijk M., Spinhoven P, Polak M, Bas B, Penninx B, Elzinga BMol dhimirka.�2014;19(7):791�800.�[PubMed]
71.�Sen S. Duman RBiol dhimirka.�2008;64(6):527�532.�[Maqaallo bilaash ah PMC][PubMed]
72.�Zhou L, Xiong J, Lim Y, iyo al. Kordhinta dhiiga proBDNF iyo reseptors-keeda ee niyad-jabka weynJ Saamaynta Dhibaatada.�2013;150(3):776�784.�[PubMed]
73.�Chen YW, Lin PY, Tu KY, Cheng YS, Wu CK, Tseng PT. Heerarka qodobka koritaanka neerfaha oo aad uga hooseeya bukaanada qaba xanuunka weyn ee niyad-jabka marka loo eego maadooyinka caafimaadka qaba: falanqayn-meta iyo dib-u-eegis habaysan.�Daawaynta Xanuunka Maskaxda ee Neuropsychiatr.�2014;11:925�933.�[Maqaallo bilaash ah PMC] [PubMed]
74.�Lin PY, Tseng PT. Hoos-u-dhac ku yimaadda heerarka unugyada glial-ka ee neurotrophic ee bukaannada qaba niyad-jabka: daraasad-analytic.�J takhtarka dhimirka.�2015;63:20�27.�[PubMed]
75.�Warner-Schmidt JL, Duman RS. VEGF oo ah bartilmaameedka suurtagalka ah ee faragelinta daweynta ee niyad-jabka.�Curr Op Pharmacol. �2008;8(1):14�19.�[Maqaallo bilaash ah PMC] [PubMed]
76.�Carvalho AF, K�hler CA, McIntyre RS, iyo al. Qodobka koritaanka xididada xididada xididada xididada sida biomarker niyad jabka cusub: falanqaynta meta.�Psychoneuroendocrinol2015;62:18�26.�[PubMed]
77.�Tseng PT, Cheng YS, Chen YW, Wu CK, Lin PY. Kordhinta heerarka koritaanka xididdada xididdada xididdada dhiigga ee bukaanka qaba xanuunka weyn ee niyad-jabka: Falanqaynta meta.�Eur Neuropsychopharmacol.�2015;25(10):1622�1630.�[PubMed]
78.�Carvalho L, Torre J, Papadopoulos A, iyo al. La'aanta faa'iidada daaweynta bukaan-socodka ee dawooyinka niyad-jabka waxay la xiriirtaa firfircoonida guud ee habka bararka.J Saamaynta Dhibaatada.�2013;148(1):136�140.�[PubMed]
79.�Clark-Raymond A, Meresh E, Hoppensteadt D, iyo al. Qodobka koritaanka xididada xididada xididada: saadaaliyaha suurtagalka ah ee jawaabta daaweynta ee niyad-jabka weyn.�World J Biol Psychiatry.�2015:1�11.�[PubMed]
80.�Isung J, Mobarrez F, Nordstr�m P, �sberg M.World J Biol Psychiatry.�2012;13(6):468�473.�[PubMed]
81.�Buttensch �n HN, Foldager L, Elfving B, Poulsen PH, Uher R, Mors O. Arrimaha Neurotrophic ee niyad-jabka ee jawaabta daawaynta.J Saamaynta Dhibaatada.�2015;183:287�294.�[PubMed]
82.�Szcz?sny E, ?lusarczyk J, G?ombik K, iyo al. Wax ku biirinta suurtagalka ah ee IGF-1 ee xanuunka niyad-jabka.�Pharmacol Rep.�2013;65(6):1622�1631.�[PubMed]
83.�Tu KY, Wu MK, Chen YW, iyo al. Heerarka koritaanka-insuliin-la mid ah ee durugsan ee bukaannada qaba xanuunka weyn ee niyad-jabka ama laba-cirifoodka marka loo eego kontaroolada caafimaadka qaba: falanqayn meta iyo dib-u-eegis hoosta Hagaha PRISMA.Med.�2016;95(4):e2411.�[Maqaallo bilaash ah PMC] [PubMed]
84.�Wu CK, Tseng PT, Chen YW, Tu KY, Lin PY. Heerarka koritaanka fibroblast-ka durugsan ee durugsan-2 ee bukaannada qaba xanuunka weyn ee niyad-jabka: Falanqaynta hore ee meta-falan ee hoos timaada tilmaamaha MOOSE.Med.�2016;95(33):e4563.�[Maqaallo bilaash ah PMC] [PubMed]
85.�He S, Zhang T, Hong B, iyo al. Hoos u dhaca korriinka serum fibroblast factor-2 heerarka daaweynta ka hor iyo ka dib bukaanka qaba xanuunka weyn ee niyad-jabka.Neurosci Lett2014;579:168�172.�[PubMed]
86.�Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Beddelka muujinta hidde-sidaha maskaxda ee neurotrophic factor iyo receptor tyrosine kinase B ee maskaxda dhimashada ka dib ee maadooyinka isdilka.Arch Gen Psychiatry.�2003;60(8):804�815.�[PubMed]
87.�Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Dib-u-eegis nidaamsan ee biomarkers-ka dheef-shiid kiimikaadka: Guddi hore oo ogaanshaha, maaraynta, iyo khatarta khatarta ah ee dadweynaha Galbeedka Virginia.Int J Med Sci2016;13(1):25.�[Maqaallo bilaash ah PMC] [PubMed]
88.�Lu XY. Mala-awaalka leptin ee niyad-jabka: xiriirka suurtagalka ah ee ka dhexeeya cilladaha niyadda iyo buurnaanta?�Curr Op Pharmacol. �2007;7(6):648�652.�[Maqaallo bilaash ah PMC] [PubMed]
89.�Wittekind DA, Kluge M. Ghrelin ee xanuunada dhimirka� Dib u eegis.Psychoneuroendocrinol2015;52:176�194.�[PubMed]
90.�Kan C, Silva N, Golden SH, iyo al. Dib-u-eegis habaysan iyo falanqayn-maro-baadhis ah oo ku saabsan xidhiidhka ka dhexeeya niyad-jabka iyo caabbinta insulin-ta.�Daryeelka Sonkorowga.�2013;36(2):480�489.�[Maqaallo bilaash ah PMC] [PubMed]
91.�Liu X, Li J, Zheng P, iyo al. Plasma lipidomics waxay daaha ka qaadaysaa calaamadaha lipid ee xanuunka weyn ee niyad jabkaDabada Bioanal Chem.�2016;408(23):6497�6507.�[PubMed]
92.�Lustman PJ, Anderson RJ, Freedland KE, De Groot M, Carney RM, Clouse RE. Niyad-jabka iyo xakamaynta glycemic liidata: dib u eegista-meta-analytic ee suugaanta.�Daryeelka Sonkorowga.�2000;23(7):934�942.�[PubMed]
93.�Maes M. Caddaynta jawaabta difaaca jirka ee niyad-jabka weyn: dib u eegis iyo mala awaal.�Prog NeuroPsychopharmacol Biol Psychiatry.�1995;19(1):11�38.�[PubMed]
94.�Zheng H, Zheng P, Zhao L, iyo al. Ogaanshaha saadaalinta niyad-jabka weyn iyadoo la adeegsanayo metabolomics-ku-saleysan NMR iyo mashiinka taageeridda faleebo-jibaaran-yar.Clinica Chimica Acta.�2017;464:223�227.[PubMed]
95.�Xia Q, Wang G, Wang H, Xie Z, Fang Y.J Clin waa dhakhtarka dhimirka2009;19:241�243.
96.�Kaufman J, DeLorenzo C, Choudhury S, Parsey RV. Soo-dhoweeyaha 5-HT 1A ee xanuunka weyn ee niyad-jabka.�Eur Neuropsychopharmacology.�2016;26(3):397�410.�[Maqaallo bilaash ah PMC] [PubMed]
97.�Jacobsen JP, Krystal AD, Krishnan KRR, Caron MG. Adjunctive 5-Hydroxytryptophan si tartiib tartiib ah u sii deynaya niyad-jabka u adkeysiga daaweynta: bukaan-socod iyo sabab macquul ah.Trends Pharmacol Sci.�2016;37(11):933�944.�[Maqaallo bilaash ah PMC] [PubMed]
98.�Salamone JD, Correa M, Yohn S, Cruz, LL, San Miguel N, Alatorre L. Farmashiistaha habdhaqanka doorashada dadaalka laxidhiidha: Dopamine, niyad-jabka, iyo kala duwanaanshaha shakhsi ahaaneed.�Hababka Dhaqanka.�2016;127:3�17.�[PubMed]
99.�Coplan JD, Gopinath S, Abdallah CG, Berry BR. Mala-awaal neurobiological ah ee niyad-jabka u adkaysta daawaynta.Dhaqanka hore ee Neurosci.�2014;8:189.[Maqaallo bilaash ah PMC] [PubMed]
100.�Popa D, Cerdan J, Rep�rant C, iyo al. Daraasad dheer oo ku saabsan qulqulka 5-HT inta lagu jiro daawaynta fluoxetine dabadheeraad ah iyadoo la adeegsanayo farsamo cusub oo microdialysis joogto ah oo ku jirta culeyska jiirka ee shucuurta aadka u sarreeya.Eur J Pharmacol.�2010;628(1):83�90.�[PubMed]
101.�Atake K, Yoshimura R, Hori H, iyo al. Duloxetine, oo ah horjoogaha dib-u-qaadista noradrenaline ee xulashada, ayaa kordhay heerarka balaasmaha ee 3-methoxy-4-hydroxyphenylglycol laakiin ma aha homovanillic acid ee bukaanka qaba xanuunka weyn ee niyad-jabka.Clin Psychopharmacol Neurosci2014;12(1):37�40.�[Maqaallo bilaash ah PMC][PubMed]
102.�Ueda N, Yoshimura R, Shinkai K, Nakamura J. Heerarka Plasma ee dheef-shiid kiimikaadka catecholamine waxay saadaaliyaan jawaabta sulpiride ama fluvoxamine ee niyad-jabka weyn.Pharmacopsychiatry.�2002;35(05):175�181.[PubMed]
103.�Yamana M, Atake K, Katsuki A, Hori H.J Walaaca Niyad-jabka.�2016;5: 222.
104.�Parker KJ, Schatzberg AF, Lyons DM. Dhinacyada neuroendocrine ee hypercortisolism ee niyad-jabka weyn.�Horm Behav.�2003;43(1):60�66.�[PubMed]
105.�Stetler C, Miller GE. Niyad-jabka iyo firfircoonida hypothalamic-pituitary-adrenal: soo koobid tiro ahaan afartan sano oo cilmi-baaris ah.Psychosom Med.�2011;73(2):114�126.�[PubMed]
106.�Herane Vives A, De Angel V, Papadopoulos A, iyo al. Xiriirka ka dhexeeya cortisol, walbahaarka iyo jirrooyinka dhimirka: aragtiyo cusub oo la adeegsanayo falanqaynta timaha.�J takhtarka dhimirka.�2015;70:38�49.�[PubMed]
107.�Fischer S, Strawbridge R, Vives AH, Cleare AJ. Cortisol sida saadaaliya jawaabta daaweynta nafsaaniga ah ee xanuunada niyad-jabka: dib-u-eegis nidaamsan iyo falanqayn-mero.�Br J Dhimirka2017;210(2):105�109.�[PubMed]
108.�Anacker C, Zunszain PA, Carvalho LA, Pariante CM. Soo-dhoweeyaha Glucocorticoid: xudunta niyad-jabka iyo daawaynta niyad-jabka?�Cilmi-nafsiga endocrinology. �2011;36(3):415�425.�[Maqaallo bilaash ah PMC][PubMed]
109.�Markopoulou K, Papadopoulos A, Juruena MF, Poon L, Pariante CM, Cleare AJ. Saamiga cortisol/DHEA ee niyad-jabka u adkaysta daawaynta.�Psychoneuroendocrinol2009;34(1):19�26.�[PubMed]
110.�Joffe RT, Pearce EN, Hennessey JV, Ryan JJ, Stern RA. Subclinical hypothyroidism, niyadda, iyo garashada ee dadka waaweyn ee waaweyn: dib u eegis.�Int J Geriatr dhimirka.�2013;28(2):111�118.�[Maqaallo bilaash ah PMC][PubMed]
111.�Duval F, Mokrani MC, Erb A, iyo al. Chronobiological hypothalamic�pituitaryPsychoneuroendocrinol2015;59:71�80.�[PubMed]
112.�Marsden W. Balaastii Synaptic ee niyad-jabka: molecular, cell iyo functional correlates.�Prog Neuropsychopharmacol Biol Psychiatry.�2013;43:168�184.�[PubMed]
113.�Duman RS, Voleti B. Wadooyinka calaamadaynta ee ka hooseeya pathophysiology iyo daaweynta niyad-jabka: hababka cusub ee wakiilada dhaqsaha badan.Trends Neurosci.�2012;35(1):47�56.[Maqaallo bilaash ah PMC] [PubMed]
114.�Ripke S, Wray NR, Lewis CM, iyo al. Falanqaynta mega ee daraasadaha ururka genome-wide ee xanuunka weyn ee niyad-jabka.�Mol dhimirka.�2013;18(4):497�511.�[Maqaallo bilaash ah PMC] [PubMed]
115.�Mullins N, Power R, Fisher H, iyo al. dhexgalka polygenic iyo dhibaatooyinka deegaanka ee aetiology ee xanuunka weyn ee niyad-jabka.�Cilmi-nafsiga Med.�2016;46(04):759�770.�[Maqaallo bilaash ah PMC] [PubMed]
116.�Lewis S. Xanuunada neerfaha: telomereska iyo niyad-jabka.�Nat Rev Neurosci.�2014;15(10): 632.[PubMed]
117.�Lindqvist D, Epel ES, Mellon SH, iyo al. Xanuunada dhimirka iyo dhererka telomere leukocyte: hababka hoose ee xidhiidhiya jirrooyinka dhimirka iyo gabowga gacanta.Neurosci Biobehav Rev.�2015;55:333�364.�[Maqaallo bilaash ah PMC] [PubMed]
118.�McCall WV. Biomarker-hawlaha nasashada si loo saadaaliyo jawaabta SSRI-yada ee xanuunka weyn ee niyad-jabka.�J takhtarka dhimirka.�2015;64:19�22.�[Maqaallo bilaash ah PMC] [PubMed]
119.�Schuch FB, Deslandes AC, Stubbs B, Gosmann NP, da Silva CTB, de Almeida Fleck MP. Saamaynta neerfaha ee jimicsiga ee xanuunka weyn ee niyad-jabka: dib u eegis nidaamsan.�Neurosci Biobehav Rev.�2016;61:1�11.�[PubMed]
120.�Foster JA, Neufeld K-AM. dhidibka maskaxda: sida microbiome-ku u saameeyo walaaca iyo niyad-jabka.�Trends Neurosci.�2013;36(5):305�312.�[PubMed]
121.�Quattrocki E, Baird A, Yurgelun-Todd D. Dhinacyada nafleyda ee xidhiidhka ka dhexeeya sigaarka iyo niyad-jabka.�Harv Rev Psychiatry.�2000;8(3):99�110.�[PubMed]
122.�Maes M, Kubera M, Obuchuwiczwa E, Goehler L, Brzeszcz J. NiyadjabNeuro Endocrinol Lett2011;32(1):7�24.�[PubMed]
123.�Miller G, Rohleder N, Cole SW. Cadaadiska joogtada ah ee dadka dhexdooda wuxuu saadaaliyaa firfircoonida dariiqyada calaamadinta ka-hortagga iyo ka-hortagga bararka lix bilood ka dib.Psychosom Med.�2009;71(1):57.�[Maqaallo bilaash ah PMC][PubMed]
124.�Steptoe A, Hamer M, Chida Y. Saamaynta diiqada nafsiga ah ee degdega ah ee ku saabsan wareegga wareegga arrimaha bararka ee bini'aadamka: dib u eegis iyo falanqayn meta.�Dabeecada maskaxda ee difaaca jirka.�2007;21(7):901�912.�[PubMed]
125.�Danish A, Moffitt TE, Harrington H, iyo al. Waayo-aragnimada carruurnimada ee xun iyo arrimaha halista u ah dadka waaweyn ee cudurrada da'da la xiriira: niyad-jabka, bararka, iyo ururinta calaamadaha halista dheef-shiid kiimikaadka.Arch Pediatr Adolesc Med.�2009;163(12):1135�1143.�[Maqaallo bilaash ah PMC] [PubMed]
126.�Deenishka A, Pariante CM, Caspi A, Taylor A, Poulton R. Daawaynta carruurnimada waxay saadaalisaa caabuqa qaangaarka ee daraasadda nolosha.�Proc Natl Acad Sci US A.�2007;104(4):1319�1324.�[Maqaallo bilaash ah PMC][PubMed]
127.�Deenishka A, Caspi A, Williams B, iyo al. Ku-xidhka nafleyda ee walbahaarka iyada oo loo marayo hababka caabuqa ee carruurnimada.�Mol dhimirka.�2011;16(3):244�246.�[Maqaallo bilaash ah PMC] [PubMed]
128.�Suzuki A, Poon L, Kumari V, Cleare AJ. Eexda cabsida ee habaynta wajiga shucuureed ka dib dhaawaca caruurnimada oo calaamad u ah adkeysiga iyo u nuglaanshaha niyad-jabka.Ilmaha si xun ula dhaqma.�2015;20(4):240�250.�[PubMed]
129.�Strawbridge R, Young AH. dhidibka HPA iyo habacsanaanta garashada ee khalkhalka niyada. Gudaha: McIntyre RS, Cha DS, tafatirayaasha.�Waxyeellada Garashada ee Xanuunka Niyad-jabka Weyn: Ku-xirnaanta Kiliinikada, Qaybaha Nafleyda, iyo Fursadaha Daawaynta.�Cambridge: Jaamacadda Cambridge Press; 2016. bogga 179�193.
130.�Keller J, Gomez R, Williams G, iyo al. dhidibka HPA ee niyad jabka weyn: cortisol, calaamadaha kiliinikada iyo kala duwanaanshiyaha hidda-socodka ayaa saadaaliya garashada.Mol dhimirka.�2016 Agoosto 16; �Epub.�[Maqaallo bilaash ah PMC] [PubMed]
131.�Hanson ND, Owens MJ, Nemeroff CB. Niyad-jabka, antidepressants, iyo neurogenesis: dib-u-qiimeyn xasaasi ah.�Neuropsychopharmacol2011;36(13):2589�2602.�[Maqaallo bilaash ah PMC] [PubMed]
132.�Chen Y, Baram TZ. Dhanka fahamka sida diiqada nolosha hore ay dib ugu habayso shabakadaha maskaxda iyo maskaxda.�Neuropsychopharmacol2015;41(1):197�206.�[Maqaallo bilaash ah PMC] [PubMed]
133.�Porter RJ, Gallagher P, Thompson JM, Young AH. Naafanimada neerfaha ee bukaanada aan daroogada lahayn ee qaba xanuunka weyn ee niyad-jabka.�Br J Dhimirka2003;182:214�220.�[PubMed]
134.�Gallagher P, Robinson L, Gray J, Young A.Aust NZJ Cilmi-nafsiga2007;41(1):54�61.�[PubMed]
135.�Pittenger C, Duman RS. Cadaadiska, niyad-jabka, iyo neuroplasticity: isku-dhafka hababka.�Neuropsychopharmacol2008;33(1):88�109.�[PubMed]
136.�Bckman L, Nyberg L, Lindenberger U, Li SC, Farde L. Isku xidhka da'da, dopamine, iyo garashada: heerka hadda iyo rajada mustaqbalka.�Neurosci Biobehav Rev.�2006;30(6):791�807.�[PubMed]
137.�Allison DJ, Ditor DS. etiology bararka caadiga ah ee niyad-jabka iyo garashada daciifnimada: bartilmaameed daweyn.J xanuunka neerfaha.�2014;11:151.[Maqaallo bilaash ah PMC] [PubMed]
138.�Rosenblat JD, Brietzke E, Mansur RB, Maruschak NA, Lee Y, McIntyre RS. Caabuqa sida substrate neurobiological ee garaadka daciifnimada laba-cirifoodka: caddaynta, pathophysiology iyo saamaynta daaweynta.�J Saamaynta Dhibaatada.�2015;188:149�159.�[PubMed]
139.�Krogh J, Benros ME, J�rgensen MB, Vesterager L, Elfving B, Nordentoft MDabeecada maskaxda ee difaaca jirka.�2014;35:70�76.�[PubMed]
140.�Soares CN, Zitek B. Dareenka hormoonka taranka iyo khatarta niyad-jabka ee wareegga nolosha dheddigga: sii socoshada nuglaanta?J Maskaxda Neurosci.�2008;33(4):331.�[Maqaallo bilaash ah PMC] [PubMed]
141.�Hiles SA, Baker AL, de Malmanche T, Atia J. Falanqaynta-meta ee kala duwanaanshaha IL-6 iyo IL-10 ee u dhexeeya dadka qaba niyad-jabka iyo kuwa aan qabin: sahaminta sababaha kala duwanaanshaha.Dabeecada maskaxda ee difaaca jirka.�2012;26(7):1180�1188.�[PubMed]
142.�Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. dheecaanka adipokine dufanka Visceral waxa ay la xiriirtaa caabuqa habaysan ee dadka buuran.Sonkorowga.�2007;56(4):1010�1013.�[PubMed]
143.�Divani AA, Luo X, Datta YH, Flaherty JD, Panoskaltsis-Mortari A. Saamaynta uurqaadida hormoonnada afka iyo siilka ee biomarkers dhiigga bararka.Dhexdhexaadiyeyaasha caabuqa.�2015;2015: 379501.[Maqaallo bilaash ah PMC] [PubMed]
144.�Ramsey JM, Cooper JD, Penninx BW, Bahn S. Kala duwanaanshiyaha biomarkers serum ee leh galmada iyo heerka hoormoonka dheddigga: Saamaynta tijaabooyinka bukaan-socodka.�Sci Rep.�2016;6:26947.[Maqaallo bilaash ah PMC] [PubMed]
145.�Eyre H, Lavretsky H, Kartika J, Qassim A.Pharmacopsychiatry.�2016;49(3):85�96.[Maqaallo bilaash ah PMC] [PubMed]
146.�Hiles SA, Baker AL, de Malmanche T, Attia J. Interleukin-6, borotiinka C-reactive iyo interleukin-10 ka dib daawaynta lidka diiqadda ee dadka niyad-jabka leh: falanqaynta meta.�Cilmi-nafsiga Med.�2012;42(10):2015�2026.�[PubMed]
147.�Janssen DG, Caniato RN, Verster JC, Baune BT. Dib-u-eegis cilmi-nafsiyeedka neuroimmunological ee cytokines ee ku lug leh jawaab-celinta daaweynta niyad-jabka.�Hum Psychopharmacol.�2010;25(3):201�215.�[PubMed]
148.�Artigas F. Serotonin reseptors ee ku lug leh saamaynta lidka ku ah niyad-jabka.�Pharmacol Ther. �2013;137(1):119�131.�[PubMed]
149.�Lee BH, Kim YK. Doorarka BDNF ee pathophysiology ee niyad-jabka weyn iyo daawaynta niyad-jabka.�Baaritaanka Dhimirka.�2010;7(4):231�235.�[Maqaallo bilaash ah PMC] [PubMed]
150.�Hashimoto K. biomarkers bararka sida saadaaliyayaal kala duwan ee jawaab-celinta niyad-jabka.Int J Mol Sci2015;16(4):7796�7801.�[Maqaallo bilaash ah PMC] [PubMed]
151.�Goldberg D. Kala duwanaanshaha niyad-jabka weyn�Cilmi-nafsiga Adduunka.�2011;10(3):226�228.[Maqaallo bilaash ah PMC] [PubMed]
152.�Arnow BA, Blasey C, Williams LM, iyo al. Niyad-jabka wuxuu hoos yimaadaa saadaalinta jawaab-celinta niyad-jabka: warbixin ka timid tijaabada iSPOT-D.Waxaan ahay J maskaxiyan.�2015;172(8):743�750.�[PubMed]
153.�Kunugi H, Hori H, Ogawa S. Calaamadaha biochemical ee hoos u dhigaya xanuunka murugada weyn.�Cilmi-nafsiga Clin Neurosci2015;69(10):597�608.�[PubMed]
154.�Baune B, Stuart M, Gilmour A, iyo al. Xidhiidhka u dhexeeya noocyada hoose ee niyad-jabka iyo cudurrada wadnaha iyo xididdada: dib u eegis nidaamsan oo lagu daydo noolaha.�Transl Maskaxda.�2012;2(3): e92.[Maqaallo bilaash ah PMC] [PubMed]
155.�Vogelzangs N, Duivis HE, Beekman AT, iyo al. Ururka xanuunada niyad-jabka, sifooyinka niyad-jabka iyo dawooyinka lidka diiqada ee caabuqa leh.�Transl Maskaxda.�2012;2: e79.[Maqaallo bilaash ah PMC] [PubMed]
156.�Lamers F, Vogelzangs N, Merikangas K, De Jonge P.Mol dhimirka.�2013;18(6):692�699.�[PubMed]
157.�Penninx BW, Milaneschi Y, Lamers F.BMC Med.�2013;11(1): 1.[Maqaallo bilaash ah PMC] [PubMed]
158.�Capuron L, Su S, Miller AH, iyo al. Calaamadaha murugada iyo dheef-shiid kiimikaadka: bararku ma xidhiidhinta hoose baa?Biol dhimirka.�2008;64(10):896�900.�[Maqaallo bilaash ah PMC] [PubMed]
159.�Dantzer R, O�Connor JC, Freund GG, Johnson RW, Kelley KW. Laga soo bilaabo caabuq ilaa jirro iyo niyad-jab: marka habka difaaca jirka uu hoos u dhigo maskaxda.�Nat Rev Neurosci.�2008;9(1):46�56.[Maqaallo bilaash ah PMC] [PubMed]
160.�Maes M, Berk M, Goehler L, iyo al. Niyad-jabka iyo habdhaqanka jirrada ayaa ah jawaabaha Janus soo wajaha ee waddooyinka bararka la wadaago.�BMC Med.�2012;10:66.[Maqaallo bilaash ah PMC] [PubMed]
161.�Merikangas KR, Jin R, He JP, iyo al. Baahitaanka iyo isku xidhka xanuunka laba-cirifoodka ee hindisaha sahanka caafimaadka dhimirka ee aduunka.�Arch Gen Psychiatry.�2011;68(3):241�251.�[Maqaallo bilaash ah PMC][PubMed]
162.�Hirschfeld RM, Lewis L, Vornik LA. Aragtida iyo saamaynta xanuunka laba-cirifoodka: intee in le'eg ayaan dhab ahaantii nimid? Natiijooyinka ururka niyad-jabka iyo niyad-jabka qaranka 2000 ee sahanka shakhsiyaadka qaba xanuunka laba-cirifoodka.�J Clin waa dhakhtarka dhimirka2003;64(2):161�174.�[PubMed]
163.�Young AH, MacPherson H. Ogaanshaha xanuunka laba-cirifoodka.�Br J Dhimirka2011;199(1):3�4.[PubMed]
164.�VHringer PA, Perlis RH. Takoorka u dhexeeya laba-cirifoodka iyo xanuunka weyn ee niyad-jabka.�Dhakhtarka maskaxda ee Clin North Am.�2016;39(1):1�10.�[PubMed]
165.�Becking K, Spijker AT, Hoencamp E, Penninx BW, Schoevers RA.PLoS One.�2015;10(7):e0133898.�[Maqaallo bilaash ah PMC] [PubMed]
166.�Huang TL, Lin FC. Heerarka borotiinka C-reactive-dareen-sare ee bukaanka qaba xanuunka weyn ee niyad-jabka iyo waallida laba-cirifoodka.�Prog NeuroPsychopharmacol Biol Psychiatry.�2007;31(2):370�372.�[PubMed]
167.�Angst J, Gamma A, Endrass J. Waxyaabaha halista u ah laba-cirifoodka iyo spectra niyad-jabka.Baaritaanka maskaxda ee Acta.�2003;418:15�19.�[PubMed]
168.�Fekadu A, Wooderson S, Donaldson C, iyo al. Qalab dhinacyo badan leh oo lagu qiyaaso iska caabbinta daaweynta niyad-jabka: Habka diyaarinta Maudsley.J Clin waa dhakhtarka dhimirka2009;70(2):177.�[PubMed]
169.�Papakostas G, Shelton R, Kinrys G, iyo al. Qiimaynta cilmi-baadhisyo kala duwan, baaritaanka bayooloji ee serum-ku salaysan ee xanuunka weyn ee niyad-jabka: tijaabo tijaabo ah iyo daraasad ku celcelin ah.Mol dhimirka.�2013;18(3):332�339.�[PubMed]
170.�Fan J, Han F, Liu H. Caqabadaha falanqaynta xogta waaweyn.�Natl Sci Rev.�2014;1(2):293�314.[Maqaallo bilaash ah PMC] [PubMed]
171.�Li L, Jiang H, Qiu Y, Ching WK, Vassiliadis VS. Helitaanka biomarkers-ka dheef-shiid kiimikaadka: falanqaynta qulqulka iyo habka shabakada falcelinta falcelinta.�BMC Syst Biol.2013;7(Salaadda 2):S13.�[Maqaallo bilaash ah PMC][PubMed]
172.�Patel MJ, Khalaf A, Aizenstein HJ. Barashada niyad-jabka iyadoo la adeegsanayo sawir-qaadista iyo hababka barashada mashiinka.�Sawirka NeuroImage Clin.�2016;10:115�123.�[Maqaallo bilaash ah PMC] [PubMed]
173.�Lanquillon S..Neuropsychopharmacol2000;22(4):370�379.�[PubMed]
174.�Lindqvist D, Janelidze S, Erhardt S, Tr�skman-Bendz L, Engstr�m GBaaritaanka maskaxda ee Acta.�2011;124(1):52�61.�[PubMed]
175.�Hidalgo-Mazzei D, Murru A, Reinares M, Vieta E, Colom F. Xog weyn oo ku saabsan caafimaadka dhimirka: mustaqbal kala daadsan oo adag.Cilmi-nafsiga Adduunka.�2016;15(2):186�187.�[Maqaallo bilaash ah PMC] [PubMed]
176.�Dallada C-DGotPG Aqoonsiga goobta khatarta ah ee saamaynta la wadaago ee shanta cudur ee dhimirka ee waaweyn: falanqayn genome-ballaaran.�Lancet.�2013;381(9875):1371�1379.�[Maqaallo bilaash ah PMC] [PubMed]
177.�Dipnall JF, Pasco JA, Berk M, iyo al. Isku-dubarid xogta macdanta, barashada mashiinka iyo tirakoobyada dhaqameed si loo ogaado biomarkers ee la xidhiidha niyad-jabka.�PLoS One.�2016;11(2):e0148195.�[Maqaallo bilaash ah PMC][PubMed]
178.�K�hler O, Benros ME, Nordentoft M, iyo al. Saamaynta daawaynta ka-hortagga caabuqa ee niyad-jabka, calaamadaha niyad-jabka, iyo saamaynta xun: dib-u-eegis nidaamsan iyo falanqayn-maro-falanqaynta tijaabooyinka bukaan-socodka ee randomized.Cilmi-nafsiga JAMA2014;71(12):1381�1391.�[PubMed]
179.�Wolkowitz OM, Reus VI, Chan T, iyo al. Daaweynta Antiglucocorticoid ee niyad-jabka: ketoconazole laba-indho la'aanBiol dhimirka.�1999;45(8):1070�1074.�[PubMed]
180.�McAllister-Williams RH, Anderson IM, Finkelmeyer A, iyo al. Kordhinta daawada niyad-jabka ah ee metyrapone ee niyad-jabka u adkaysta (daraasadda ADD): laba-indho-indho, aan kala sooc lahayn, tijaabo-koontarool placebo.Lancet Psychiatry.�2016;3(2):117�127.�[PubMed]
181.�Gallagher P, Dhalinyaro AH. Mifepristone (RU-486) ​​daawaynta niyad-jabka iyo cilmi nafsiga: Dib-u-eegis ku saabsan saamaynta daweynta.Daawaynta Xanuunka Maskaxda ee Neuropsychiatr.�2006;2(1):33�42.�[Maqaallo bilaash ah PMC] [PubMed]
182.�Otte C, Hinkelmann K, Moritz S, iyo al. Wax-ka-beddelka soo-dhoweynta macdanta-corticoid-ka sida daawaynta-kordhinta ee niyad-jabka: randomized, double-inard, placebo-control proof-of- opinion study.J takhtarka dhimirka.�2010;44(6):339�346.�[PubMed]
183.�Ozbolt LB, Nemeroff CB. Habaynta dhidibka HPA ee daawaynta ciladaha niyadda.�Xanuunka Dhimirka.�2013;51:1147�1154.
184.�Walker AK, Budac DP, Bisulco S, iyo al. Xayiraadda soo-dhoweynta NMDA ee ketamine waxay tirtirtaa lipopolysaccharide-ku-abuuray dabeecad niyad-jab leh oo ku jira jiirarka C57BL/6J.Neuropsychopharmacol2013;38(9):1609�1616.�[Maqaallo bilaash ah PMC] [PubMed]
185.�Lesp�rance F, Frasure-Smith N, St-Andr� E, Turecki G, Lesp�rance P, Wisniewski SR. Waxtarka kaabista omega-3 ee niyad-jabka weyn: tijaabo la kantaroolay oo randomized ah.�J Clin waa dhakhtarka dhimirka2010;72(8):1054�1062.�[PubMed]
186.�Kim S, Bae K, Kim J, iyo al. Isticmaalka statins ee daawaynta niyad-jabka ee bukaanka qaba xanuunka wadnaha ee degdega ah.�Transl Maskaxda.�2015;5(8):e620.�[Maqaallo bilaash ah PMC] [PubMed]
187.�Shishehbor MH, Brennan ML, Aviles RJ, iyo al. Statins-ku waxay kor u qaadaan saamaynta antioxidant-ka ee habaysan ee xoogga leh iyada oo loo marayo dariiqyo gaar ah oo barar ahWareega.�2003;108(4):426�431.�[PubMed]
188.�Mercier A, Auger-Aubin I, Lebeau JP, iyo al. Caddaynta daawoyinka lidka diiqadda ee xaaladaha aan maskaxda ahayn ee daryeelka aasaasiga ah: falanqaynta tilmaamaha iyo dib u eegista habaysan.�BMC Dhaqanka Qoyska.�2013;14(1):55.�[Maqaallo bilaash ah PMC] [PubMed]
189.�Freland L, Beaulieu JM. Kahortagga GSK3 ee lithium, laga bilaabo hal unugyo ilaa shabakadaha calaamadaha.�Hore Mol Neurosci.�2012;5:14.[Maqaallo bilaash ah PMC] [PubMed]
190.�Horowitz MA, Zunszain PA. Neuroimmune iyo neuroendocrine aan caadi ahayn ee niyad-jabka: laba dhinac oo isku mid ah.Ann NY Acad Sci.�2015;1351(1):68�79.�[PubMed]
191.�Juruena MF, Cleare AJ. Isku dhafka u dhexeeya niyad-jabka caadiga ah, xanuunka xilliyeedka iyo daal daba-dheeraada.�Rev Bras Psiquiatr.�2007;29:S19�S26.�[PubMed]
192.�Casr�n E, Kojima M. Neurotrophic-maskaxeed-maskaxeed-ka-soo-baxa ee xanuunka niyadda iyo daawaynta niyad-jabka.�Neurobiol Dis. �2017;97(Pt B):119�126.�[PubMed]
193.�Pan A, Keum N, Okereke OI, iyo al. Xiriirka laba geesoodka ah ee ka dhexeeya niyad-jabka iyo dheef-shiid kiimikaadka dib-u-eegis nidaamsan iyo falanqayn-maro-falanqaynta daraasaadka cudurrada faafa.Daryeelka Sonkorowga.�2012;35(5):1171�1180.�[Maqaallo bilaash ah PMC] [PubMed]
194.�Carvalho AF, Rocha DQ, McIntyre RS, iyo al. Adipokines sida biomarkers niyad-jabka soo baxaya: dib-u-eegis nidaamsan iyo falanqayn-maro.�J Nasinta Dhimirka.�2014;59:28�37.�[PubMed]
195.�Wise T, Cleare AJ, Herane A, Young AH.Daawaynta Xanuunka Maskaxda ee Neuropsychiatr.�2014;10:1509�1522.[Maqaallo bilaash ah PMC] [PubMed]
196.�Tamatam A, Khanum F, Bawa AS. Calaamadaha hidde-sideyaasha niyad-jabka.�Hindi J Hum Genet2012;18(1):20.�[Maqaallo bilaash ah PMC] [PubMed]
197.�Yoshimura R, Nakamura J, Shinkai K, Ueda N. Jawaabta kiliinikada ee daaweynta antidepressant iyo heerarka 3-methoxy-4-hydroxyphenylglycol: dib u eegis yar.Prog Neuropsychopharmacol Biol Psychiatry.�2004;28(4):611�616.�[PubMed]
198.�Pierscionek T, Adekunte O, Watson S, Ferrier N, Alabi A. Doorka corticosteroids ee ka hortagga niyad-jabka.ChronoPhysics Ther.�2014;4:87�98.
199.�Hage MP, Azar ST. Xiriirka ka dhexeeya shaqada tayroodh iyo niyad-jabka.�J Thyroid Res.�2012;2012:590648.[Maqaallo bilaash ah PMC] [PubMed]
200.�Dunn EC, Brown RC, Dai Y, iyo al. Go'aamiyaasha hidda-socodka ee niyad-jabka: natiijooyinkii ugu dambeeyay iyo tilmaamaha mustaqbalka.�Harv Rev Psychiatry.�2015;23(1):1.�[Maqaallo bilaash ah PMC] [PubMed]
201.�Yang CC, Hsu YL. Dib-u-eegis lagu sameeyo accelerometry-ku-salaysan dhaqdhaqaaq-sheegayaasha dhaq-dhaqaaqa xidhan kara ee la socodka dhaqdhaqaaqa jidhka.�Dareemayaasha.�2010;10(8):7772�7788.�[Maqaallo bilaash ah PMC] [PubMed]
Xir Accordion

Baaxadda Xirfadda Tababarka *

Macluumaadka halkan ku qoran "Doorka Biomarkers ee Niyad-jabka"looma talagelin in lagu beddelo xiriirka qof-ka-qof ah ee leh xirfadle daryeel caafimaad oo u qalma ama takhtar shati haysta mana aha talo caafimaad. Waxaan kugu dhiirigelineynaa inaad sameyso go'aamo daryeel caafimaad oo ku saleysan cilmi-baaristaada iyo iskaashigaaga xirfadle daryeel caafimaad oo u qalma.

Macluumaadka Blog-ga & Wada-hadallada Xadka

Baaxadda macluumaadka waxay ku kooban tahay Chiropractic, murqaha, dawooyinka jireed, fayoobida, gacan ka geysata etiological khalkhalka viscerosomatic gudaha bandhigyada kiliinikada, dhaqdhaqaaqa kiliinikada ee somatovisceral reflex ee la xidhiidha, dhismooyinka subluxation, arrimaha caafimaadka xasaasiga ah, iyo/ama maqaallada daawada shaqaynta, mowduucyada, iyo doodaha.

Waanu bixina oo soo bandhignaa iskaashiga bukaan-socodka oo leh takhasusyo ka kala socda qaybo kala duwan. Khabiir kastaa waxa lagu maamulaa baaxadda ku-dhaqankooda xirfadeed iyo awooddooda shatiga. Waxaan isticmaalnaa borotokoolka caafimaadka iyo fayo-qabka shaqada si aan u daaweyno oo u taageerno daryeelka dhaawacyada ama cilladaha habka muruqyada.

Fiidiyowyadayada, qoraaladayada, mawduucyada, mawduucyada, iyo aragtiyadayadu waxay daboolayaan arrimaha kiliinikada, arrimaha, iyo mawduucyada la xidhiidha oo si toos ah ama si dadban u taageera baaxadda hawlqabadkayaga caafimaad.*

Xafiiskayagu waxa uu si macquul ah isku dayay in uu bixiyo tixraacyo taageero ah waxana uu aqoonsaday daraasadda cilmi-baadhiseed ee la xidhiidha ama daraasadaha taageeraya qoraaladayada. Waxaan siinaa nuqulo ka mid ah daraasadaha cilmi-baarista ee taageeraya ee loo heli karo golayaasha sharciyeynta iyo dadweynaha marka la codsado.

Waxaan fahamsanahay inaan daboolno arrimaha u baahan sharaxaad dheeri ah oo ku saabsan sida ay gacan uga geysan karto qorshe daryeel gaar ah ama hab maamuuska daaweynta; haddaba, si aad uga sii wada hadasho mowduuca kor ku xusan, fadlan si xor ah u weydiiso Dr. Alex Jimenez, DC, ama nagala soo xiriir 915-850-0900.

Waxaan halkan u nimid inaan kaa caawinno adiga iyo qoyskaaga.

Barako

Dr. Alex Jimenez DC, MSACP, RN*, CCST, IFMCP*, CIFM*, ATN*

email: Tababaraha@elpasofunctionalmedicine.com

Ruqsad u haysta sidii Dhakhtar Chiropractic (DC) gudaha Texas & New Mexico*
Shatiga Texas DC # TX5807, Shatiga New Mexico DC # NM-DC2182

Ruqsad u haysta Kalkaaliso Diiwaangashan (RN*) in Florida
Shatiga Florida ee RN # RN9617241 (Maamulka No. 3558029)
Xaaladda is haysta: Shatiga Dawlad-goboleed badan: Loo oggolaaday inuu ku tababarto Gobollada 40*

Dr. Alex Jimenez DC, MSACP, RN* CIFM*, IFMCP*, ATN*, CCST
Kadhkayga Ganacsiga Dijital ah